Asthma Management
Asthma Management. Mobile Phone Number 01987073965, 01797522136. Asthma management involves a combination of medication, following a written asthma action plan, and lifestyle adjustments like avoiding triggers. Inhalers, including preventers and/or reliever inhalers, are the primary treatment. A good management plan includes regular check-ups, staying active (with appropriate precautions), quitting smoking, maintaining a healthy weight, and managing other conditions like GERD or allergies.

Asthma Management Topics are available in some courses of HRTD Medical Institute. These Courses are Paramedical Courses, DMA Courses, DMS Courses, DPM Courses, DMDS Course, PDT Courses and PGT Courses. All these courses are available in HRTD Medical Institute. These Course are important for First Aid Providers, Primary Treatment Providers, and Village Doctors ( Polly Chikitsok). HRTD Medical Institute is an Organization of HRTD Limited Which is Registered by The Govt of The Peoples Republic of Bangladesh.
Medication
- Inhalers: The main treatment is breathing in medication through an inhaler.
- Reliever inhalers: Used only when symptoms occur.
- Preventer inhalers: Used daily to help prevent symptoms.
- Maintenance and reliever therapy (MART): One inhaler used for both daily maintenance and when symptoms flare up.
- Other medications: Depending on the severity, other drugs like leukotriene modifiers or biologics may be prescribed.
- Inhaler technique: Proper technique is crucial for effective drug absorption, which involves inhaling deeply while pressing the inhaler and holding your breath for about 10 seconds afterward.
Asthma action plan
- Work with a healthcare provider to create a personalized, written asthma action plan.
- This plan provides instructions for routine management and what to do if symptoms worsen or an emergency occurs.
- Regular check-ups to review your symptoms, lung function, and action plan are essential.
Lifestyle adjustments
- Avoid triggers: Identify and avoid personal asthma triggers, which can include smoke, dust mites, and certain allergens.
- Exercise: Engage in regular physical activity, which can strengthen lungs. Talk to your doctor about a safe level of exercise and use medication as needed to prevent symptoms during activity.
- Healthy weight: Maintain a healthy weight, as being overweight can worsen asthma symptoms.
- Quitting smoking: Stop smoking and avoid all forms of tobacco and e-cigarette vapor.
- Other conditions: Treat other health issues that can impact asthma, such as hay fever, allergies, GERD, and sleep apnea.
- Sleep: Ensure you get enough quality sleep by establishing a regular sleep schedule and creating a calming bedtime routine.
Definition of Asthma
Asthma is a chronic lung condition that causes inflammation and narrowing of the airways, leading to recurring episodes of wheezing, coughing, shortness of breath, and chest tightness. Symptoms can vary from mild to severe and are often triggered by factors like allergens, exercise, or cold air. While there is no cure, asthma can be managed and controlled through medication, avoiding triggers, and having an action plan.
Causes of Asthma
Asthma is caused by a combination of genetic and environmental factors, leading to inflammation and narrowing of the airways. Risk factors include a family history of asthma or allergies, childhood respiratory infections, and exposure to secondhand smoke or air pollution. Triggers that can cause symptoms include allergens like pollen and dust mites, irritants like smoke and strong odors, respiratory infections, physical activity, and weather changes.
Genetic and environmental factors
- Family history: A family history of asthma or allergies increases your risk.
- Childhood factors: Lower birth weight, premature birth, and certain early childhood illnesses are linked to a higher risk of developing asthma.
- Environmental exposure: Early-life exposure to factors like secondhand smoke, air pollution, and certain substances at work can contribute to its development.
- Obesity: Being overweight or obese is a risk factor for developing and having more severe asthma.
Common triggers for asthma attacks
- Allergens: Airborne allergens like pollen, dust mites, mold spores, pet dander, and cockroach waste.
- Irritants: Air pollutants, smoke from tobacco or wood fires, and strong fumes or odors from chemicals, perfumes, or cleaning products.
- Respiratory infections: Illnesses like the common cold, flu, or COVID-19.
- Weather: Cold, dry air, sudden changes in weather, or high humidity.
- Physical activity: Exercise, particularly in cold air.
- Medications: Certain drugs, including some pain relievers like aspirin and other NSAIDs, and some beta-blockers.
- Strong emotions: Stress or other strong emotional responses can trigger symptoms.
- Food additives: Sulfites and other preservatives added to some foods and beverages.
Clinical Feature of Asthma
The clinical manifestations of asthma are the cardinal symptoms of cough, wheezing, shortness of breath, and chest tightness. These symptoms can range from mild to severe and often occur in episodes, which may be triggered by factors like exercise, allergies, or cold air. Symptoms can also worsen at night or in the early morning. During a severe asthma attack, symptoms intensify and require immediate medical attention.
Common symptoms
- Coughing: Often worse at night, a cough can be a primary symptom.
- Wheezing: A high-pitched whistling or rattling sound, particularly when breathing out.
- Shortness of breath: Difficulty breathing, which can range from mild to severe, and may occur after exercise.
- Chest tightness: A feeling of pressure or squeezing in the chest, as if a rope is tightening around it.
Other manifestations
- Worsening symptoms at night or early morning: These episodes can disrupt sleep.
- Symptoms triggered by exercise: An asthma attack can be triggered by physical exertion.
- Difficulty talking: In severe cases, talking may be difficult.
- Signs of a severe attack: In addition to the cardinal symptoms, severe attacks may involve rapid breathing, a pale or sweaty face, and changes in skin color around the lips, fingertips, or nail beds, which may appear bluish or gray/white.
Diagnosis of Asthma
Asthma is diagnosed through a combination of medical history, physical exam, and lung function tests, primarily spirometry, which measures how much air you can breathe out. A doctor will also consider your symptoms, family history, and may perform other tests like allergy tests, a peak flow test, or a FeNO test to confirm the diagnosis and identify triggers.
Key diagnostic tools and tests
- Spirometry: This is the most common and recommended test. You breathe forcefully into a device called a spirometer, which measures the amount of air you can inhale and exhale, and how fast you can do so.
- Peak flow test: You blow into a device called a peak flow meter to measure how fast you can exhale. This can help monitor asthma over time.
- FeNO test: A test that measures the level of nitric oxide in your breath, which can indicate airway inflammation and certain types of allergic asthma.
- Challenge test: If other tests are inconclusive, a doctor may have you breathe in a substance that irritates the airways. This test is done in a hospital and shows how sensitive your airways are.
- Allergy tests: Skin or blood tests can help determine if allergies to things like pollen, dust mites, or animal dander are triggering your symptoms.
- Treatment trial: Your doctor may have you start an asthma treatment to see if your symptoms improve, which can help confirm a diagnosis.
What to expect during diagnosis
- Medical and family history: Your doctor will ask about your symptoms, how often they occur, and any family history of asthma or allergies.
- Physical examination: A doctor will listen to your lungs for wheezing or other sounds and check for other signs like chest tightness.
- Symptom patterns: Your doctor will analyze the pattern of your symptoms, such as if they worsen at night or with exercise.
Important considerations
- Other conditions: Asthma symptoms can overlap with other respiratory conditions, so it’s important for a healthcare professional to rule out other diagnoses.
- No single test: There is no single test that can diagnose asthma; diagnosis is based on a combination of factors.
- Consult a doctor: Only a healthcare professional can provide an accurate diagnosis. If you are concerned you may have asthma, contact your doctor.
Investigation for Asthma
Asthma investigation involves a combination of medical history, physical exam, and lung function tests like spirometry and peak flow measurements. Blood tests for eosinophils, a FeNO test to measure airway inflammation, and sometimes an allergy or CT scan of the sinuses may also be performed. Doctors also use a treatment trial, observing if asthma medications improve symptoms.
Medical history and physical exam
- Your doctor will ask about your symptoms, when they occur, and potential triggers.
- They will perform a physical exam, which includes listening to your lungs.
Lung function tests
- Spirometry: You will breathe forcefully into a machine that measures how much air you can breathe out and how fast. A bronchodilator may be given, and the test repeated to see if your lung function improves.
- Peak flow meter: This is a handheld device that you use at home to measure how fast you can blow air out of your lungs. You may use it for several weeks to track your lung function and identify patterns.
- FeNO (fractional exhaled nitric oxide) test: This test measures the level of nitric oxide in your breath, which can indicate inflammation in your airways.
Other potential tests
- Blood test: Checks for a high number of eosinophils, a type of white blood cell associated with airway inflammation.
- Allergy testing: Can help identify triggers like pollen, dust mites, or pet dander.
- CT scan of sinuses: May be ordered if the doctor suspects a sinus infection (sinusitis), which can worsen asthma.
- Treatment trial: Your doctor may prescribe asthma medication and see if it improves your symptoms.
Important considerations
- There is no single test for asthma; diagnosis relies on a combination of factors.
- Diagnosing asthma in very young children can be difficult, and lung function tests are not possible for those under 5.
- Spirometry is not suitable for all patients, so your doctor will choose the most appropriate test(s) for you.
CT scan of the sinuses
A sinus CT scan is a non-invasive imaging test that uses X-rays to create detailed cross-sectional pictures of the paranasal sinuses, the air-filled cavities in the bones of the face. This scan is the most reliable way to diagnose problems like sinusitis, inflammation, polyps, fluid, and anatomical blockages, helping doctors determine the best course of treatment. The procedure is quick and painless, though you may feel a slight warming sensation and a metallic taste if a contrast dye is used.
What it is
- Imaging technique: A CT scan takes multiple X-ray images from different angles to create detailed cross-sectional views of the sinuses, unlike a standard X-ray.
- Purpose: It is used to diagnose and evaluate a variety of sinus problems, including chronic sinusitis, inflammation, fluid buildup, polyps, and structural abnormalities.
- Accuracy: It is considered the most accurate and best imaging method for evaluating the sinuses.
What to expect
- Preparation: You should wear loose-fitting clothing and remove all metal jewelry, including hairpins and hearing aids, beforehand. You may be asked to avoid eating or drinking for a few hours, especially if contrast dye will be used.
- During the scan: You will lie on a table, and a scanner will rotate around your head to capture the images. The procedure is painless and usually takes less than 5 minutes, although the total appointment may take longer.
- Contrast dye: In some cases, a contrast material is injected through an IV to help highlight structures. This can cause a brief feeling of warmth and a metallic taste.
- After the scan: If contrast dye was used, you may be advised to drink extra fluids. You can return to your normal activities immediately.
Why it’s used
- Diagnosis: It helps diagnose sinus issues with high accuracy.
- Surgical planning: It is an integral part of planning for sinus surgery, providing a detailed “road map” of the anatomy for the surgeon.
- Treatment guidance: The detailed images help doctors create a tailored treatment plan for you.
Why CT scan is important for Asthma Patient
A CT scan is important for asthma patients, especially those with severe or uncontrolled asthma, because it provides more detailed imaging than a chest X-ray, allowing doctors to identify structural changes in the airways. It can help diagnose complications like mucus plugs or bronchiectasis, rule out other conditions, and provide a better understanding of air trapping. This helps in making a correct diagnosis and developing a more effective treatment plan.
Key reasons for importance
- Detailed imaging: CT scans offer a much higher-resolution view of the airways and lung tissue compared to standard X-rays.
- Diagnosis of complications: They can identify structural changes associated with severe asthma, such as thickened airway walls, mucus impaction, and bronchiectasis.
- Differential diagnosis: CT scans help differentiate asthma from other conditions that may have similar symptoms or be mistaken for asthma, such as allergic bronchopulmonary aspergillosis (ABPA), eosinophilic granulomatosis with polyangiitis (EGPA), or COPD.
- Assessment of disease severity: In severe asthma, CT can reveal patterns of remodeling and air trapping that correlate with functional decline and disease severity.
- Treatment planning: By identifying the specific structural issues, doctors can create more targeted treatment strategies for difficult-to-treat asthma cases.
Why CT scan of sinuses is important for Asthma Patient
A CT scan is important for asthma patients to identify or rule out underlying chronic rhinosinusitis (sinusitis) and nasal polyps, which can worsen asthma control. It helps doctors diagnose and manage co-existing sinus conditions by showing inflammation, mucosal thickening, or polyps that require specific treatment. Identifying these issues is crucial for selecting the correct treatment, particularly certain types of biologics for severe, eosinophilic asthma with CRSwNP.
Key reasons for CT scans in asthma patients
- Diagnosing and assessing sinus disease: CT scans are the best tool for evaluating the paranasal sinuses and nasal cavity to find conditions like chronic rhinosinusitis (CRS) or nasal polyps, which are common in patients with severe asthma.
- Identifying “treatable traits”: The scan can identify specific issues like nasal polyps that are linked to a type of inflammation (type-2-predominant) that responds well to certain medical treatments, like biologic therapies.
- Improving treatment decisions: By clearly showing the extent of sinus inflammation or obstruction, a CT scan helps doctors choose the most effective treatment plan, which may include a combination of therapies for both the sinuses and the lungs.
- Monitoring treatment response: The scan can be used to monitor how well treatment for sinusitis is working, as demonstrated by improvement in CT scores over time.
- Managing “upper and lower airway” disease simultaneously: The scan allows doctors to address both upper (sinus) and lower (lung) airway inflammation at the same time, which is crucial for achieving better asthma control.
Why CT scan of lungs is important for Asthma Patient
A CT scan is important for asthma patients because it provides detailed anatomical information that helps identify structural changes, diagnose complications, and differentiate asthma from other conditions, especially in severe or difficult-to-treat cases. It can reveal issues like airway wall thickening, mucus plugs, air trapping, and bronchiectasis, which may not be visible on a standard chest X-ray.
Detailed assessment of the lungs
- Visualizes structural changes: CT scans show details like bronchial wall thickening and narrowing, which are key findings in asthma.
- Identifies complications: It helps identify complications that worsen asthma, such as mucus plugs or bronchiectasis.
- Detects air trapping: High-resolution CT (HRCT) can show signs of air trapping, indicating how effectively air is moving in and out of the lungs.
Differential diagnosis
- Rules out other conditions: CT scans help distinguish asthma from other diseases with similar symptoms, like emphysema, chronic bronchitis, or allergic bronchopulmonary aspergillosis (ABPA).
- Diagnoses comorbid conditions: It can identify other conditions that may be contributing to a patient’s poor asthma control, such as chronic rhinosinusitis or eosinophilic granulomatosis with polyangiitis (EGPA).
Monitoring and treatment planning
- Assesses severity: CT scans can provide a more detailed assessment of asthma severity and disease progression over time.
- Evaluates treatment response: Quantitative CT techniques are being studied to monitor the effectiveness of treatments by measuring changes in airway structure.
How Pet dander trigger Asthma
Pet dander triggers asthma when a person’s immune system mistakenly identifies the allergens in dander, saliva, or urine as harmful, leading to inflammation and tightening of the airways. The immune response releases chemicals that cause symptoms like coughing, wheezing, and shortness of breath, which are characteristic of an asthma attack. The microscopic dander particles can remain airborne, stick to furniture, and travel on clothing, making them difficult to avoid.
The immune system’s response
- Allergen identification: For someone with pet allergies, the immune system creates antibodies that incorrectly flag proteins in pet dander (tiny flakes of skin), saliva, or urine as dangerous.
- Inflammatory response: The next time these allergens are encountered, the immune system overreacts and releases chemicals like histamine into the bloodstream.
- Airway constriction: This chemical release leads to swelling in the airways and causes the muscles around them to tighten, which is the physical response that causes asthma symptoms.
How dander affects the body
- Airborne particles: Dander is very small and can stay airborne for long periods, especially with air circulation.
- Surface contamination: It sticks to surfaces like clothing, carpets, and furniture, making it hard to get rid of.
- Inhalation: When inhaled, these particles can trigger asthma symptoms such as coughing, wheezing, chest tightness, and shortness of breath.
What you can do
- Reduce exposure: Keep pets out of the bedroom and off upholstered furniture.
- Improve air quality: Use HEPA air cleaners and vacuum carpets and furniture regularly with a vacuum that has a HEPA filter.
- Maintain cleanliness: Wash your hands after touching pets, wash bedding and clothes in hot water, and have someone else brush the pet outside to minimize dander release.
āĻĒā§āώāĻž āĻĒā§āϰāĻžāĻŖā§āϰ āĻā§āĻļāĻāĻŋ āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āĻāĻžāϰāĻŖ āĻšāϝāĻŧ āϝāĻāύ āĻāĻāĻāύ āĻŦā§āϝāĻā§āϤāĻŋāϰ āϰā§āĻ āĻĒā§āϰāϤāĻŋāϰā§āϧ āĻŦā§āϝāĻŦāϏā§āĻĨāĻž āĻā§āϞ āĻāϰ⧠āĻā§āĻļāĻāĻŋ, āϞāĻžāϞāĻž āĻŦāĻž āĻĒā§āϰāϏā§āϰāĻžāĻŦā§āϰ āĻ ā§āϝāĻžāϞāĻžāϰā§āĻā§āύāĻā§ āĻā§āώāϤāĻŋāĻāĻžāϰāĻ āĻšāĻŋāϏā§āĻŦā§ āĻļāύāĻžāĻā§āϤ āĻāϰā§, āϝāĻžāϰ āĻĢāϞ⧠āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϤ⧠āĻĒā§āϰāĻĻāĻžāĻš āĻāĻŦāĻ āĻāĻžāύāĻāĻžāύ āĻāĻžāĻŦ āĻĻā§āĻāĻž āĻĻā§āϝāĻŧāĨ¤āϰā§āĻ āĻĒā§āϰāϤāĻŋāϰā§āϧ āĻā§āώāĻŽāϤāĻž āĻāĻŽāύ āϰāĻžāϏāĻžāϝāĻŧāύāĻŋāĻ āĻĒāĻĻāĻžāϰā§āĻĨ āύāĻŋāϰā§āĻāϤ āĻāϰ⧠āϝāĻž āĻāĻžāĻļāĻŋ, āĻļā§āĻŦāĻžāϏāĻāώā§āĻ āĻāĻŦāĻ āĻļā§āĻŦāĻžāϏāĻāώā§āĻā§āϰ āĻŽāϤ⧠āϞāĻā§āώāĻŖ āϏā§āώā§āĻāĻŋ āĻāϰā§, āϝāĻž āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āĻāĻā§āϰāĻŽāĻŖā§āϰ āĻŦā§āĻļāĻŋāώā§āĻā§āϝāĨ¤ āĻā§āώā§āĻĻā§āϰ āĻā§āĻļāĻāĻŋāϰ āĻāĻŖāĻžāĻā§āϞāĻŋ āĻŦāĻžāϤāĻžāϏ⧠āĻĨāĻžāĻāϤ⧠āĻĒāĻžāϰā§, āĻāϏāĻŦāĻžāĻŦāĻĒāϤā§āϰ⧠āϞā§āĻā§ āĻĨāĻžāĻāϤ⧠āĻĒāĻžāϰ⧠āĻāĻŦāĻ āĻĒā§āĻļāĻžāĻā§āϰ āĻāĻĒāϰ āĻā§āϰāĻŽāĻŖ āĻāϰāϤ⧠āĻĒāĻžāϰā§, āϝāĻžāϰ āĻĢāϞ⧠āĻāĻā§āϞāĻŋ āĻāĻĄāĻŧāĻžāύ⧠āĻāĻ āĻŋāύ āĻšāϝāĻŧā§ āĻĒāĻĄāĻŧā§āĨ¤
āϰā§āĻ āĻĒā§āϰāϤāĻŋāϰā§āϧ āĻŦā§āϝāĻŦāϏā§āĻĨāĻžāϰ āĻĒā§āϰāϤāĻŋāĻā§āϰāĻŋāϝāĻŧāĻž
- āĻ ā§āϝāĻžāϞāĻžāϰā§āĻā§āύ āĻļāύāĻžāĻā§āϤāĻāϰāĻŖ: āĻĒā§āώāĻž āĻĒā§āϰāĻžāĻŖā§āϰ āĻ ā§āϝāĻžāϞāĻžāϰā§āĻāĻŋ āĻāĻā§ āĻāĻŽāύ āĻŦā§āϝāĻā§āϤāĻŋāϰ āĻā§āώā§āϤā§āϰā§, āϰā§āĻ āĻĒā§āϰāϤāĻŋāϰā§āϧ āĻŦā§āϝāĻŦāϏā§āĻĨāĻž āĻ ā§āϝāĻžāύā§āĻāĻŋāĻŦāĻĄāĻŋ āϤā§āϰāĻŋ āĻāϰ⧠āϝāĻž āĻĒā§āώāĻž āĻĒā§āϰāĻžāĻŖā§āϰ āĻā§āĻļāĻāĻŋ (āϤā§āĻŦāĻā§āϰ āĻā§āώā§āĻĻā§āϰ āĻāĻŖā§āĻĄ), āϞāĻžāϞāĻž āĻŦāĻž āĻĒā§āϰāϏā§āϰāĻžāĻŦā§ āĻĨāĻžāĻāĻž āĻĒā§āϰā§āĻāĻŋāύāĻā§ āĻŦāĻŋāĻĒāĻā§āĻāύāĻ āĻšāĻŋāϏāĻžāĻŦā§ āĻā§āϞāĻāĻžāĻŦā§ āĻāĻŋāĻšā§āύāĻŋāϤ āĻāϰā§āĨ¤
- āĻĒā§āϰāĻĻāĻžāĻšāĻāύāĻ āĻĒā§āϰāϤāĻŋāĻā§āϰāĻŋāϝāĻŧāĻž: āĻĒāϰā§āϰ āĻŦāĻžāϰ āϝāĻāύ āĻāĻ āĻ ā§āϝāĻžāϞāĻžāϰā§āĻā§āύā§āϰ āĻŽā§āĻā§āĻŽā§āĻāĻŋ āĻšāĻāϝāĻŧāĻž āĻšāϝāĻŧ, āϤāĻāύ āϰā§āĻ āĻĒā§āϰāϤāĻŋāϰā§āϧ āĻŦā§āϝāĻŦāϏā§āĻĨāĻž āĻ āϤāĻŋāϰāĻŋāĻā§āϤ āĻĒā§āϰāϤāĻŋāĻā§āϰāĻŋāϝāĻŧāĻž āĻĻā§āĻāĻžāϝāĻŧ āĻāĻŦāĻ āϰāĻā§āϤāĻĒā§āϰāĻŦāĻžāĻšā§ āĻšāĻŋāϏā§āĻāĻžāĻŽāĻŋāύā§āϰ āĻŽāϤ⧠āϰāĻžāϏāĻžāϝāĻŧāύāĻŋāĻ āĻĒāĻĻāĻžāϰā§āĻĨ āĻā§āĻĄāĻŧā§ āĻĻā§āϝāĻŧāĨ¤
- āĻļā§āĻŦāĻžāϏāύāĻžāϞ⧠āϏāĻāĻā§āĻāύ: āĻāĻ āϰāĻžāϏāĻžāϝāĻŧāύāĻŋāĻ āύāĻŋāĻāϏāϰāĻŖā§āϰ āĻĢāϞ⧠āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϤ⧠āĻĢā§āϞ⧠āϝāĻžāϝāĻŧ āĻāĻŦāĻ āϤāĻžāĻĻā§āϰ āĻāĻžāϰāĻĒāĻžāĻļā§āϰ āĻĒā§āĻļā§āĻā§āϞāĻŋ āĻļāĻā§āϤ āĻšāϝāĻŧā§ āϝāĻžāϝāĻŧ, āϝāĻž āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āϞāĻā§āώāĻŖāĻā§āϞāĻŋāϰ āĻāĻžāϰāĻŖ āĻļāĻžāϰā§āϰāĻŋāĻ āĻĒā§āϰāϤāĻŋāĻā§āϰāĻŋāϝāĻŧāĻžāĨ¤
āĻā§āĻļāĻāĻŋ āĻā§āĻāĻžāĻŦā§ āĻļāϰā§āϰāĻā§ āĻĒā§āϰāĻāĻžāĻŦāĻŋāϤ āĻāϰā§
- āĻŦāĻžāϝāĻŧā§āĻŦāĻžāĻšāĻŋāϤ āĻāĻŖāĻž: āĻā§āĻļāĻāĻŋ āĻā§āĻŦāĻ āĻā§āĻ āĻāĻŦāĻ āĻĻā§āϰā§āĻ āϏāĻŽāϝāĻŧ āϧāϰ⧠āĻŦāĻžāϝāĻŧā§āĻŦāĻžāĻšāĻŋāϤ āĻĨāĻžāĻāϤ⧠āĻĒāĻžāϰā§, āĻŦāĻŋāĻļā§āώ āĻāϰ⧠āĻŦāĻžāϝāĻŧā§ āϏāĻā§āĻāĻžāϞāύā§āϰ āϏāĻŽāϝāĻŧāĨ¤
- āĻĒā§āώā§āĻ āĻĻā§āώāĻŖ: āĻāĻāĻŋ āĻĒā§āĻļāĻžāĻ, āĻāĻžāϰā§āĻĒā§āĻ āĻāĻŦāĻ āĻāϏāĻŦāĻžāĻŦā§āϰ āĻŽāϤ⧠āĻĒā§āώā§āĻ ā§āϰ āϏāĻžāĻĨā§ āϞā§āĻā§ āĻĨāĻžāĻā§, āϝāĻžāϰ āĻĢāϞ⧠āĻāĻāĻŋ āĻ āĻĒāϏāĻžāϰāĻŖ āĻāϰāĻž āĻāĻ āĻŋāύ āĻšāϝāĻŧā§ āĻĒāĻĄāĻŧā§āĨ¤
- āĻļā§āĻŦāĻžāϏ-āĻĒā§āϰāĻļā§āĻŦāĻžāϏ: āĻļā§āĻŦāĻžāϏ-āĻĒā§āϰāĻļā§āĻŦāĻžāϏā§āϰ āĻŽāĻžāϧā§āϝāĻŽā§ āύā§āĻāϝāĻŧāĻž āĻšāϞā§, āĻāĻ āĻāĻŖāĻžāĻā§āϞāĻŋ āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āϞāĻā§āώāĻŖāĻā§āϞāĻŋ āϝā§āĻŽāύ āĻāĻžāĻļāĻŋ, āĻļā§āĻŦāĻžāϏāĻāώā§āĻ, āĻŦā§āĻā§ āĻāĻžāύ āĻāĻŦāĻ āĻļā§āĻŦāĻžāϏāĻāώā§āĻā§āϰ āϏā§āώā§āĻāĻŋ āĻāϰāϤ⧠āĻĒāĻžāϰā§āĨ¤
āϤā§āĻŽāĻŋ āĻāĻŋ āĻāϰāϤ⧠āĻĒāĻžāϰā§
- āĻāĻā§āϏāĻĒā§āĻāĻžāϰ āĻāĻŽāĻžāύ: āĻĒā§āώāĻž āĻĒā§āϰāĻžāĻŖā§āĻĻā§āϰ āĻļā§āĻŦāĻžāϰ āĻāϰ āĻĨā§āĻā§ āĻĻā§āϰ⧠āϰāĻžāĻā§āύ āĻāĻŦāĻ āĻāϏāĻŦāĻžāĻŦāĻĒāϤā§āϰā§āϰ āĻāϏāĻŦāĻžāĻŦāĻĒāϤā§āϰ āĻĨā§āĻā§ āĻĻā§āϰ⧠āϰāĻžāĻā§āύāĨ¤
- āĻŦāĻžāϤāĻžāϏā§āϰ āĻŽāĻžāύ āĻāύā§āύāϤ āĻāϰā§āύ: HEPA āĻāϝāĻŧāĻžāϰ āĻā§āϞāĻŋāύāĻžāϰ āĻāĻŦāĻ āĻā§āϝāĻžāĻā§āϝāĻŧāĻžāĻŽ āĻāĻžāϰā§āĻĒā§āĻ āĻāĻŦāĻ āĻāϏāĻŦāĻžāĻŦāĻĒāϤā§āϰ āύāĻŋāϝāĻŧāĻŽāĻŋāϤ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰā§āύ āϝāĻžāϤ⧠HEPA āĻĢāĻŋāϞā§āĻāĻžāϰ āĻāĻā§ āĻāĻŽāύ āĻā§āϝāĻžāĻā§āϝāĻŧāĻžāĻŽ āĻā§āϞāĻŋāύāĻžāϰ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰā§āύāĨ¤
- āĻĒāϰāĻŋāώā§āĻāĻžāϰ-āĻĒāϰāĻŋāĻā§āĻāύā§āύāϤāĻž āĻŦāĻāĻžāϝāĻŧ āϰāĻžāĻā§āύ: āĻĒā§āώāĻž āĻĒā§āϰāĻžāĻŖā§ āϏā§āĻĒāϰā§āĻļ āĻāϰāĻžāϰ āĻĒāϰ āĻāĻĒāύāĻžāϰ āĻšāĻžāϤ āϧā§āϝāĻŧā§ āύāĻŋāύ, āĻāϰāĻŽ āĻāϞ⧠āĻŦāĻŋāĻāĻžāύāĻž āĻāĻŦāĻ āĻāĻžāĻĒāĻĄāĻŧ āϧā§āϝāĻŧā§ āĻĢā§āϞā§āύ, āĻāĻŦāĻ āĻā§āĻļāĻāĻŋ āĻāĻŽāĻžāϤ⧠āĻ āύā§āϝ āĻāĻžāĻāĻā§ āĻĒā§āώāĻž āĻĒā§āϰāĻžāĻŖā§āĻāĻŋāĻā§ āĻŦāĻžāĻāϰ⧠āĻŦā§āϰāĻžāĻļ āĻāϰāϤ⧠āĻŦāϞā§āύāĨ¤
Biochemicals that are involved in Asthma
Biochemicals involved in asthma include
inflammatory mediators like histamine, leukotrienes, and prostaglandins, which cause bronchoconstriction and swelling. Other key players are cytokines such as IL-4, IL-5, and IL-13, which promote inflammation and allergic responses. Additionally, IgE is a central molecule in the allergic pathway, and there are also biochemical changes involving molecules like periostin and enzymes such as eosinophil peroxidase.
Inflammatory mediators
- Histamine: Released from mast cells, it causes smooth muscle contraction, increased vascular permeability, and mucus secretion.
- Leukotrienes: Specifically, cysteinyl leukotrienes (LTC4, LTD4, LTE4) contribute to bronchoconstriction, mucus production, and inflammation.
- Prostaglandins: Prostaglandin
D2cap D sub 2đˇ2 (
PGD2cap P cap G cap D sub 2đđēđˇ2) is released by mast cells and contributes to airway inflammation.
- Bradykinin: Formed by the enzyme kalikrein, it can cause bronchoconstriction and increase vascular permeability.
Cytokines and signaling molecules
- Interleukins (ILs):
- IL-4, IL-5, and IL-13: These Th2 cytokines promote the production of IgE, activate eosinophils, and contribute to airway inflammation.
- IL-33 and TSLP: These are signaling molecules that are significantly elevated in asthmatics and are linked to persistent airway inflammation and reduced lung function.
- T-helper 2 (Th2) pathway: The activation of this immune pathway leads to the release of the aforementioned cytokines.
- Periostin: Elevated levels are associated with IL-13 driven asthma and may indicate a patient who would benefit from therapies that block IL-4/IL-13.
Antibodies and enzymes
- Immunoglobulin E (IgE): This antibody plays a central role in atopic asthma. It binds to mast cells, and upon re-exposure to an allergen, it triggers the release of inflammatory mediators.
- Eosinophil Cationic Protein (ECP): A marker for eosinophil activity and asthma severity.
- Eosinophil Peroxidase: Increased activity is associated with asthma.
- Arginase: Increased activity is linked to asthma.
Other biochemicals
- Reactive Oxygen Species (ROS): Eosinophils can release ROS during an inflammatory response.
- Nitric Oxide (NO): Increased concentrations may occur in asthma, potentially binding to hemoglobin and reducing oxygen capacity.
āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āϏāĻžāĻĨā§ āĻāĻĄāĻŧāĻŋāϤ āĻā§āĻŦ āϰāĻžāϏāĻžāϝāĻŧāύāĻŋāĻ āĻĒāĻĻāĻžāϰā§āĻĨā§āϰ āĻŽāϧā§āϝ⧠āϰāϝāĻŧā§āĻā§
āĻšāĻŋāϏā§āĻāĻžāĻŽāĻŋāύ, āϞāĻŋāĻāĻā§āĻā§āϰāĻŋāϝāĻŧā§āύāϏāĻāĻŦāĻ āĻĒā§āϰā§āϏā§āĻāĻžāĻā§āϞā§āϝāĻžāύā§āĻĄāĻŋāύā§āϰāĻŽāϤ⧠āĻĒā§āϰāĻĻāĻžāĻšāĻāύāĻ āĻŽāϧā§āϝāϏā§āĻĨāϤāĻžāĻāĻžāϰ⧠, āϝāĻž āĻŦā§āϰāĻā§āĻā§āĻāύāϏā§āĻā§āϰāĻŋāĻāĻļāύ āĻāĻŦāĻ āĻĢā§āϞāĻž āϏā§āώā§āĻāĻŋ āĻāϰā§āĨ¤ āĻ āύā§āϝāĻžāύā§āϝ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻā§āϞā§āϝāĻŧāĻžāĻĄāĻŧ āĻšāϞ āϏāĻžāĻāĻā§āĻāĻžāĻāύ āϝā§āĻŽāύ IL-4, IL-5, āĻāĻŦāĻ IL-13, āϝāĻž āĻĒā§āϰāĻĻāĻžāĻš āĻāĻŦāĻ āĻ ā§āϝāĻžāϞāĻžāϰā§āĻāĻŋāϰ āĻĒā§āϰāϤāĻŋāĻā§āϰāĻŋāϝāĻŧāĻž āĻŦā§āĻĻā§āϧāĻŋ āĻāϰā§āĨ¤ āĻ āϤāĻŋāϰāĻŋāĻā§āϤāĻāĻžāĻŦā§, IgE āĻšāϞ āĻ ā§āϝāĻžāϞāĻžāϰā§āĻāĻŋāϰ āĻĒāĻĨā§āϰ āĻāĻāĻāĻŋ āĻā§āύā§āĻĻā§āϰā§āϝāĻŧ āĻ āĻŖā§, āĻāĻŦāĻ āĻĒā§āϰāĻŋāĻāϏā§āĻāĻŋāύā§āϰāĻŽāϤ⧠āĻ āĻŖā§ āĻāĻŦāĻ āĻāĻāϏāĻŋāύā§āĻĢāĻŋāϞ āĻĒā§āϰā§āĻā§āϏāĻŋāĻĄā§āϏā§āϰ āĻŽāϤ⧠āĻāύāĻāĻžāĻāĻŽ āĻāĻĄāĻŧāĻŋāϤ āĻā§āĻŦ āϰāĻžāϏāĻžāϝāĻŧāύāĻŋāĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύāĻ āϰāϝāĻŧā§āĻā§ āĨ¤
āĻĒā§āϰāĻĻāĻžāĻšāĻāύāĻ āĻŽāϧā§āϝāϏā§āĻĨāϤāĻžāĻāĻžāϰā§
- āĻšāĻŋāϏā§āĻāĻžāĻŽāĻŋāύ: āĻŽāĻžāϏā§āϤā§āϞ āĻā§āώ āĻĨā§āĻā§ āύāĻŋāĻāϏā§āϤ āĻšāĻāϝāĻŧāĻžāϝāĻŧ, āĻāĻāĻŋ āĻŽāϏā§āĻŖ āĻĒā§āĻļā§ āϏāĻāĻā§āĻāύ, āϰāĻā§āϤāύāĻžāϞ⧠āĻĒā§āϰāĻŦā§āĻļāϝā§āĻā§āϝāϤāĻž āĻŦā§āĻĻā§āϧāĻŋ āĻāĻŦāĻ āĻļā§āϞā§āώā§āĻŽāĻž āύāĻŋāĻāϏāϰāĻŖ āĻāĻāĻžāϝāĻŧāĨ¤
- āϞāĻŋāĻāĻā§āĻā§āϰāĻŋāϝāĻŧā§āύāϏ: āĻŦāĻŋāĻļā§āώ āĻāϰā§, āϏāĻŋāϏā§āĻā§āĻāύāĻžāĻāϞ āϞāĻŋāĻāĻā§āĻā§āϰāĻŋāϝāĻŧā§āύāϏ (LTC4, LTD4, LTE4) āĻŦā§āϰāĻā§āĻā§āĻāύāϏā§āĻā§āϰāĻŋāĻāĻļāύ, āĻļā§āϞā§āώā§āĻŽāĻž āĻā§āĻĒāĻžāĻĻāύ āĻāĻŦāĻ āĻĒā§āϰāĻĻāĻžāĻšā§ āĻ āĻŦāĻĻāĻžāύ āϰāĻžāĻā§āĨ¤
- āĻĒā§āϰā§āϏā§āĻāĻžāĻā§āϞā§āϝāĻžāύā§āĻĄāĻŋāύ: āĻĒā§āϰā§āϏā§āĻāĻžāĻā§āϞā§āϝāĻžāύā§āĻĄāĻŋāύ
D2cap D sub 2đˇ2 (
PGD2cap P cap G cap D sub 2đđēđˇ2) āĻŽāĻžāϏā§āĻ āĻā§āώ āĻĻā§āĻŦāĻžāϰāĻž āύāĻŋāĻāϏā§āϤ āĻšāϝāĻŧ āĻāĻŦāĻ āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϰ āĻĒā§āϰāĻĻāĻžāĻšā§ āĻ āĻŦāĻĻāĻžāύ āϰāĻžāĻā§āĨ¤
- āĻŦā§āϰā§āϝāĻžāĻĄāĻŋāĻāĻŋāύāĻŋāύ: āĻā§āϝāĻžāϞāĻŋāĻā§āϰā§āĻāύ āĻāύāĻāĻžāĻāĻŽ āĻĻā§āĻŦāĻžāϰāĻž āĻāĻ āĻŋāϤ, āĻāĻāĻŋ āĻŦā§āϰāĻā§āĻā§āĻāύāϏā§āĻā§āϰāĻŋāĻāĻļāύ āϏā§āώā§āĻāĻŋ āĻāϰāϤ⧠āĻĒāĻžāϰ⧠āĻāĻŦāĻ āϰāĻā§āϤāύāĻžāϞ⧠āĻĒā§āϰāĻŦā§āĻļāϝā§āĻā§āϝāϤāĻž āĻŦā§āĻĻā§āϧāĻŋ āĻāϰāϤ⧠āĻĒāĻžāϰā§āĨ¤
āϏāĻžāĻāĻā§āĻāĻžāĻāύ āĻāĻŦāĻ āϏāĻāĻā§āϤ āĻ āĻŖā§
- āĻāύā§āĻāĻžāϰāϞāĻŋāĻāĻāĻŋāύāϏ (ILs):
- IL-4, IL-5, āĻāĻŦāĻ IL-13: āĻāĻ Th2 āϏāĻžāĻāĻā§āĻāĻžāĻāύāĻā§āϞāĻŋ IgE āĻā§āĻĒāĻžāĻĻāύāĻā§ āĻā§āϏāĻžāĻšāĻŋāϤ āĻāϰā§, āĻāĻāϏāĻŋāύā§āĻĢāĻŋāϞ āϏāĻā§āϰāĻŋāϝāĻŧ āĻāϰ⧠āĻāĻŦāĻ āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϰ āĻĒā§āϰāĻĻāĻžāĻšā§ āĻ āĻŦāĻĻāĻžāύ āϰāĻžāĻā§āĨ¤
- IL-33 āĻāĻŦāĻ TSLP: āĻāĻā§āϞāĻŋ āĻšāϞ āϏāĻāĻā§āϤ āĻ āĻŖā§ āϝāĻž āĻšāĻžāĻāĻĒāĻžāύāĻŋ āϰā§āĻā§āĻĻā§āϰ āĻŽāϧā§āϝ⧠āĻāϞā§āϞā§āĻāϝā§āĻā§āϝāĻāĻžāĻŦā§ āĻŦā§āĻĻā§āϧāĻŋ āĻĒāĻžāϝāĻŧ āĻāĻŦāĻ āϏā§āĻĨāĻžāϝāĻŧā§ āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϰ āĻĒā§āϰāĻĻāĻžāĻš āĻāĻŦāĻ āĻĢā§āϏāĻĢā§āϏā§āϰ āĻāĻžāϰā§āϝāĻāĻžāϰāĻŋāϤāĻž āĻšā§āϰāĻžāϏā§āϰ āϏāĻžāĻĨā§ āϝā§āĻā§āϤāĨ¤
- āĻāĻŋ-āĻšā§āϞā§āĻĒāĻžāϰ ⧍ (Th2) āĻĒāĻĨ: āĻāĻ āϰā§āĻ āĻĒā§āϰāϤāĻŋāϰā§āϧ āĻā§āώāĻŽāϤāĻžāϰ āϏāĻā§āϰāĻŋāϝāĻŧāĻāϰāĻŖā§āϰ āĻĢāϞ⧠āĻāĻĒāϰ⧠āĻāϞā§āϞāĻŋāĻāĻŋāϤ āϏāĻžāĻāĻā§āĻāĻžāĻāύ āύāĻŋāĻāϏāϰāĻŖ āĻšāϝāĻŧāĨ¤
- āĻĒā§āϰāĻŋāĻāϏā§āĻāĻŋāύ: āĻāĻā§āĻ āĻŽāĻžāϤā§āϰāĻž IL-13 āĻĻā§āĻŦāĻžāϰāĻž āϏā§āώā§āĻ āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āϏāĻžāĻĨā§ āϏāĻŽā§āĻĒāϰā§āĻāĻŋāϤ āĻāĻŦāĻ āĻāĻāĻŋ āĻāĻŽāύ āĻāĻāĻāύ āϰā§āĻā§āĻā§ āύāĻŋāϰā§āĻĻā§āĻļ āĻāϰāϤ⧠āĻĒāĻžāϰ⧠āϝāĻŋāύāĻŋ IL-4/IL-13 āĻŦā§āϞāĻ āĻāϰ⧠āĻāĻŽāύ āĻĨā§āϰāĻžāĻĒāĻŋ āĻĨā§āĻā§ āĻāĻĒāĻā§āϤ āĻšāĻŦā§āύāĨ¤
āĻ ā§āϝāĻžāύā§āĻāĻŋāĻŦāĻĄāĻŋ āĻāĻŦāĻ āĻāύāĻāĻžāĻāĻŽ
- āĻāĻŽāĻŋāĻāύā§āĻā§āϞā§āĻŦā§āϞāĻŋāύ āĻ (IgE): āĻāĻ āĻ ā§āϝāĻžāύā§āĻāĻŋāĻŦāĻĄāĻŋ āĻ ā§āϝāĻžāĻā§āĻĒāĻŋāĻ āĻšāĻžāĻāĻĒāĻžāύāĻŋāϤ⧠āĻāĻāĻāĻŋ āĻā§āύā§āĻĻā§āϰā§āϝāĻŧ āĻā§āĻŽāĻŋāĻāĻž āĻĒāĻžāϞāύ āĻāϰā§āĨ¤ āĻāĻāĻŋ āĻŽāĻžāϏā§āĻ āĻā§āώā§āϰ āϏāĻžāĻĨā§ āĻāĻŦāĻĻā§āϧ āĻšāϝāĻŧ āĻāĻŦāĻ āĻ ā§āϝāĻžāϞāĻžāϰā§āĻā§āύā§āϰ āϏāĻāϏā§āĻĒāϰā§āĻļā§ āĻāϏāĻžāϰ āĻĒāϰ, āĻāĻāĻŋ āĻĒā§āϰāĻĻāĻžāĻšāĻāύāĻ āĻŽāϧā§āϝāϏā§āĻĨāϤāĻžāĻāĻžāϰā§āĻĻā§āϰ āĻŽā§āĻā§āϤāĻŋāϰ āϏā§āϤā§āϰāĻĒāĻžāϤ āĻāϰā§āĨ¤
- āĻāĻāϏāĻŋāύā§āĻĢāĻŋāϞ āĻā§āϝāĻžāĻāĻžāύāĻŋāĻ āĻĒā§āϰā§āĻāĻŋāύ (ECP): āĻāĻāϏāĻŋāύā§āĻĢāĻŋāϞ āĻāĻžāϰā§āϝāĻāϞāĻžāĻĒ āĻāĻŦāĻ āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āϤā§āĻŦā§āϰāϤāĻžāϰ āĻāĻāĻāĻŋ āĻāĻŋāĻšā§āύāĻŋāϤāĻāĻžāϰā§āĨ¤
- āĻāĻāϏāĻŋāύā§āĻĢāĻŋāϞ āĻĒā§āϰā§āĻā§āϏāĻŋāĻĄā§āϏ: āĻŦāϰā§āϧāĻŋāϤ āĻāĻžāϰā§āϝāĻāϞāĻžāĻĒ āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āϏāĻžāĻĨā§ āϏāĻŽā§āĻĒāϰā§āĻāĻŋāϤāĨ¤
- āĻāϰā§āĻāĻŋāύā§āϏ: āĻŦāϰā§āϧāĻŋāϤ āĻāĻžāϰā§āϝāĻāϞāĻžāĻĒ āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āϏāĻžāĻĨā§ āϏāĻŽā§āĻĒāϰā§āĻāĻŋāϤāĨ¤
āĻ āύā§āϝāĻžāύā§āϝ āĻā§āĻŦ āϰāĻžāϏāĻžāϝāĻŧāύāĻŋāĻ āĻĒāĻĻāĻžāϰā§āĻĨ
- āĻĒā§āϰāϤāĻŋāĻā§āϰāĻŋāϝāĻŧāĻžāĻļā§āϞ āĻ āĻā§āϏāĻŋāĻā§āύ āĻĒā§āϰāĻāĻžāϤāĻŋ (ROS): āĻĒā§āϰāĻĻāĻžāĻšāĻāύāĻ āĻĒā§āϰāϤāĻŋāĻā§āϰāĻŋāϝāĻŧāĻžāϰ āϏāĻŽāϝāĻŧ āĻāĻāϏāĻŋāύā§āĻĢāĻŋāϞāĻā§āϞāĻŋ ROS āύāĻŋāĻāϏāϰāĻŖ āĻāϰāϤ⧠āĻĒāĻžāϰā§āĨ¤
- āύāĻžāĻāĻā§āϰāĻŋāĻ āĻ āĻā§āϏāĻžāĻāĻĄ (NO): āĻšāĻžāĻāĻĒāĻžāύāĻŋāϤ⧠āĻāϰ āĻāύāϤā§āĻŦ āĻŦā§āĻĻā§āϧāĻŋ āĻĒā§āϤ⧠āĻĒāĻžāϰā§, āϝāĻž āĻšāĻŋāĻŽā§āĻā§āϞā§āĻŦāĻŋāύā§āϰ āϏāĻžāĻĨā§ āĻāĻŦāĻĻā§āϧ āĻšāϤ⧠āĻĒāĻžāϰ⧠āĻāĻŦāĻ āĻ āĻā§āϏāĻŋāĻā§āύ āϧāĻžāϰāĻŖāĻā§āώāĻŽāϤāĻž āĻšā§āϰāĻžāϏ āĻāϰāϤ⧠āĻĒāĻžāϰā§āĨ¤
How histamine causes asthma ?
Histamine causes asthma by triggering airway smooth muscle contraction, increasing mucus production, and causing airway swelling (edema). During an allergic reaction, mast cells in the lungs release histamine, which binds to receptors (primarily H1 receptors) on airway smooth muscle, causing it to tighten and narrow the airways, making breathing difficult. This also stimulates excessive mucus and inflammation, worsening asthma symptoms.
How histamine triggers asthma symptoms
- Bronchoconstriction: Histamine stimulates airway smooth muscles to contract, leading to a narrowing of the airways, known as bronchoconstriction.
- Mucus production: It prompts the lungs to produce more mucus, which can clog the airways.
- Airway swelling: Histamine can lead to airway mucosal edema, which is the swelling of the lining of the airways, further obstructing airflow.
- Inflammation: The release of histamine is part of the broader inflammatory response in the lungs, which can involve other immune cells and mediators that contribute to asthma’s chronic inflammation.
- Vagal nerve stimulation: Histamine can also indirectly cause bronchoconstriction by stimulating afferent vagal fibers in the airways.
āĻšāĻŋāϏā§āĻāĻžāĻŽāĻŋāύ āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϰ āĻŽāϏā§āĻŖ āĻĒā§āĻļā§ āϏāĻāĻā§āĻāύ, āĻļā§āϞā§āώā§āĻŽāĻž āĻā§āĻĒāĻžāĻĻāύ āĻŦā§āĻĻā§āϧāĻŋ āĻāĻŦāĻ āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϰ āĻĢā§āϞāĻžāĻāĻžāĻŦ (āĻāĻĄāĻŋāĻŽāĻž) āϏā§āώā§āĻāĻŋ āĻāϰā§āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āĻāĻžāϰāĻŖ āĻšāϝāĻŧ āĨ¤ āĻ ā§āϝāĻžāϞāĻžāϰā§āĻāĻŋāϰ āĻĒā§āϰāϤāĻŋāĻā§āϰāĻŋāϝāĻŧāĻžāϰ āϏāĻŽāϝāĻŧ, āĻĢā§āϏāĻĢā§āϏā§āϰ āĻŽāĻžāϏā§āĻ āĻā§āώāĻā§āϞāĻŋāĻšāĻŋāϏā§āĻāĻžāĻŽāĻŋāύ āύāĻŋāĻāϏāϰāĻŖ āĻāϰā§, āϝāĻž āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϰ āĻŽāϏā§āĻŖ āĻĒā§āĻļā§āϤ⧠āϰāĻŋāϏā§āĻĒā§āĻāϰāĻā§āϞāĻŋāϰ (āĻĒā§āϰāĻžāĻĨāĻŽāĻŋāĻāĻāĻžāĻŦā§ H1 āϰāĻŋāϏā§āĻĒā§āĻāϰ) āϏāĻžāĻĨā§ āĻāĻŦāĻĻā§āϧ āĻšāϝāĻŧ, āϝāĻžāϰ āĻĢāϞ⧠āĻāĻāĻŋ āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āĻā§ āĻļāĻā§āϤ āĻāĻŦāĻ āϏāĻāĻā§āĻāĻŋāϤ āĻāϰā§, āϝāĻžāϰ āĻĢāϞ⧠āĻļā§āĻŦāĻžāϏ āύāĻŋāϤ⧠āĻ āϏā§āĻŦāĻŋāϧāĻž āĻšāϝāĻŧāĨ¤ āĻāĻāĻŋ āĻ āϤāĻŋāϰāĻŋāĻā§āϤ āĻļā§āϞā§āώā§āĻŽāĻž āĻāĻŦāĻ āĻĒā§āϰāĻĻāĻžāĻšāĻā§āĻ āĻāĻĻā§āĻĻā§āĻĒāĻŋāϤ āĻāϰā§, āϝāĻž āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āϞāĻā§āώāĻŖāĻā§āϞāĻŋāĻā§ āĻāϰāĻ āĻāĻžāϰāĻžāĻĒ āĻāϰā§āĨ¤
āĻšāĻŋāϏā§āĻāĻžāĻŽāĻŋāύ āĻā§āĻāĻžāĻŦā§ āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āϞāĻā§āώāĻŖāĻā§āϞāĻŋāĻā§ āĻā§āϰāĻŋāĻāĻžāϰ āĻāϰā§
- āĻŦā§āϰāĻā§āĻā§āĻāύāϏā§āĻā§āϰāĻŋāĻāĻļāύ: āĻšāĻŋāϏā§āĻāĻžāĻŽāĻŋāύ āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϰ āĻŽāϏā§āĻŖ āĻĒā§āĻļā§āĻā§āϞāĻŋāĻā§ āϏāĻāĻā§āĻāύ⧠āĻāĻĻā§āĻĻā§āĻĒāĻŋāϤ āĻāϰā§, āϝāĻžāϰ āĻĢāϞ⧠āĻļā§āĻŦāĻžāϏāύāĻžāϞ⧠āϏāĻāĻā§āĻāĻŋāϤ āĻšāϝāĻŧ, āϝāĻž āĻŦā§āϰāĻā§āĻā§āĻāύāϏā§āĻā§āϰāĻŋāĻāĻļāύ āύāĻžāĻŽā§ āĻĒāϰāĻŋāĻāĻŋāϤāĨ¤
- āĻļā§āϞā§āώā§āĻŽāĻž āĻā§āĻĒāĻžāĻĻāύ: āĻāĻāĻŋ āĻĢā§āϏāĻĢā§āϏāĻā§ āĻāϰāĻ āĻļā§āϞā§āώā§āĻŽāĻž āĻā§āĻĒāĻžāĻĻāύ āĻāϰāϤ⧠āĻĒā§āϰāϰā§āĻāĻŋāϤ āĻāϰā§, āϝāĻž āĻļā§āĻŦāĻžāϏāύāĻžāϞ⧠āĻŦāύā§āϧ āĻāϰ⧠āĻĻāĻŋāϤ⧠āĻĒāĻžāϰā§āĨ¤
- āĻļā§āĻŦāĻžāϏāύāĻžāϞ⧠āĻĢā§āϞ⧠āϝāĻžāĻāϝāĻŧāĻž: āĻšāĻŋāϏā§āĻāĻžāĻŽāĻŋāύā§āϰ āĻāĻžāϰāĻŖā§ āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϤ⧠āĻŽāĻŋāĻāĻā§āϏāĻžāϞ āĻāĻĄāĻŋāĻŽāĻž āĻšāϤ⧠āĻĒāĻžāϰā§, āϝāĻž āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϰ āĻāϏā§āϤāϰāĻŖā§āϰ āĻĢā§āϞ⧠āϝāĻžāĻāϝāĻŧāĻž, āϝāĻž āĻŦāĻžāϝāĻŧā§āĻĒā§āϰāĻŦāĻžāĻšāĻā§ āĻāϰāĻ āĻŦāĻžāϧāĻžāĻā§āϰāϏā§āϤ āĻāϰā§āĨ¤
- āĻĒā§āϰāĻĻāĻžāĻš: āĻšāĻŋāϏā§āĻāĻžāĻŽāĻŋāύā§āϰ āύāĻŋāĻāϏāϰāĻŖ āĻĢā§āϏāĻĢā§āϏā§āϰ āĻŦā§āĻšāϤā§āϤāϰ āĻĒā§āϰāĻĻāĻžāĻšāĻāύāĻ āĻĒā§āϰāϤāĻŋāĻā§āϰāĻŋāϝāĻŧāĻžāϰ āĻ āĻāĻļ, āϝāĻž āĻ āύā§āϝāĻžāύā§āϝ āϰā§āĻ āĻĒā§āϰāϤāĻŋāϰā§āϧāĻ āĻā§āώ āĻāĻŦāĻ āĻŽāϧā§āϝāϏā§āĻĨāϤāĻžāĻāĻžāϰā§āĻĻā§āϰ āĻāĻĄāĻŧāĻŋāϤ āĻāϰāϤ⧠āĻĒāĻžāϰ⧠āϝāĻž āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āĻĻā§āϰā§āĻāϏā§āĻĨāĻžāϝāĻŧā§ āĻĒā§āϰāĻĻāĻžāĻšā§ āĻ āĻŦāĻĻāĻžāύ āϰāĻžāĻā§āĨ¤
- āĻā§āϝāĻžāĻāĻžāϞ āϏā§āύāĻžāϝāĻŧā§ āĻāĻĻā§āĻĻā§āĻĒāύāĻž: āĻšāĻŋāϏā§āĻāĻžāĻŽāĻŋāύ āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϤ⧠āĻ ā§āϝāĻžāĻĢā§āϰā§āύā§āĻ āĻā§āϝāĻžāĻāĻžāϞ āĻĢāĻžāĻāĻŦāĻžāϰāĻā§āϞāĻŋāĻā§ āĻāĻĻā§āĻĻā§āĻĒāĻŋāϤ āĻāϰ⧠āĻĒāϰā§āĻā§āώāĻāĻžāĻŦā§ āĻŦā§āϰāĻā§āĻā§āĻāύāϏā§āĻā§āϰāĻŋāĻāĻļāύ āĻāĻāĻžāϤ⧠āĻĒāĻžāϰā§āĨ¤
How Leukotrienes cause Asthma
Leukotrienes cause asthma by
causing bronchoconstriction, inflammation, and increased mucus production in the airways. When released during an asthma trigger like an allergen, these molecules bind to specific receptors on airway smooth muscle, causing it to contract and narrow the airways, leading to breathing difficulties. They also increase blood vessel permeability and inflammation in the lungs and draw more inflammatory cells, such as eosinophils, to the area.
How leukotrienes cause asthma symptoms
- Bronchoconstriction: Leukotrienes, particularly cysteinyl leukotrienes (
CysLTscap C y s cap L cap T sđļđĻđ đŋđđ ), are potent constrictors of airway smooth muscles, leading to the narrowing of the airways.
- Inflammation: They attract inflammatory cells like eosinophils to the airways, which contributes to long-term airway hypersensitivity and swelling.
- Increased mucus production: Leukotrienes stimulate the secretion of mucus, which can further obstruct the airways.
- Increased vascular permeability: They make blood vessels in the airways more permeable, which can lead to swelling (edema) in the airway walls.
- Reduced mucociliary clearance: This effect impairs the lungs’ ability to clear mucus and debris, making breathing more difficult.
Leukotrienes in the asthma cycle
- Triggering: During an asthma attack, mast cells release leukotrienes.
- Action: These leukotrienes then bind to receptors on other cells, including airway smooth muscle.
- Symptoms: This triggers the cascade of effects that lead to bronchoconstriction, inflammation, and mucus production, resulting in an asthma attack.
- Chronic asthma: In chronic asthma, leukotrienes can contribute to the general hyperresponsiveness of the airways by attracting eosinophils that also produce leukotrienes.
āϞāĻŋāĻāĻā§āĻā§āϰāĻŋāϝāĻŧā§āύāĻā§āϞāĻŋ
āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϤā§āĻŦā§āϰāĻā§āĻā§āĻāύāϏā§āĻā§āϰāĻŋāĻāĻļāύ, āĻĒā§āϰāĻĻāĻžāĻšāĻāĻŦāĻ āĻļā§āϞā§āώā§āĻŽāĻž āĻā§āĻĒāĻžāĻĻāύāĻŦā§āĻĻā§āϧāĻŋ āĻāϰ⧠āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āĻāĻžāϰāĻŖ āĻšāϝāĻŧ āĨ¤ āĻ ā§āϝāĻžāϞāĻžāϰā§āĻā§āύā§āϰ āĻŽāϤ⧠āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āĻā§āϰāĻŋāĻāĻžāϰā§āϰ āϏāĻŽāϝāĻŧ āĻāĻ āĻ āĻŖā§āĻā§āϞāĻŋ āĻļā§āĻŦāĻžāϏāύāĻžāϞ⧠āĻŽāϏā§āĻŖ āĻĒā§āĻļā§āϰ āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āϰāĻŋāϏā§āĻĒā§āĻāϰā§āϰ āϏāĻžāĻĨā§ āĻāĻŦāĻĻā§āϧ āĻšāϝāĻŧ, āϝāĻžāϰ āĻĢāϞ⧠āĻāĻāĻŋ āĻļā§āĻŦāĻžāϏāύāĻžāϞ⧠āϏāĻāĻā§āĻāĻŋāϤ āĻāĻŦāĻ āϏāĻāĻā§āĻāĻŋāϤ āĻšāϝāĻŧ, āϝāĻžāϰ āĻĢāϞ⧠āĻļā§āĻŦāĻžāϏāĻāώā§āĻ āĻšāϝāĻŧāĨ¤ āĻāĻā§āϞāĻŋ āĻĢā§āϏāĻĢā§āϏ⧠āϰāĻā§āϤāύāĻžāϞ⧠āĻĒā§āϰāĻŦā§āĻļāϝā§āĻā§āϝāϤāĻž āĻāĻŦāĻ āĻĒā§āϰāĻĻāĻžāĻš āĻŦā§āĻĻā§āϧāĻŋ āĻāϰ⧠āĻāĻŦāĻ āĻāĻāϏāĻŋāύā§āĻĢāĻŋāϞā§āϰ āĻŽāϤ⧠āĻāϰāĻ āĻĒā§āϰāĻĻāĻžāĻšāĻāύāĻ āĻā§āώāĻā§āϞāĻŋāĻā§ āĻāĻ āĻ āĻā§āĻāϞ⧠āĻā§āύ⧠āĻāύā§āĨ¤
āϞāĻŋāĻāĻā§āĻā§āϰāĻŋāϝāĻŧā§āύ āĻā§āĻāĻžāĻŦā§ āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āϞāĻā§āώāĻŖ āϏā§āώā§āĻāĻŋ āĻāϰā§
- āĻŦā§āϰāĻā§āĻā§āĻāύāϏā§āĻā§āϰāĻŋāĻāĻļāύ: āϞāĻŋāĻāĻā§āĻā§āϰāĻŋāύ, āĻŦāĻŋāĻļā§āώ āĻāϰ⧠āϏāĻŋāϏā§āĻā§āĻāύāĻžāĻāϞ āϞāĻŋāĻāĻā§āĻā§āϰāĻŋāύ (
CysLTscap C y s cap L cap T sđļđĻđ đŋđđ ), āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϰ āĻŽāϏā§āĻŖ āĻĒā§āĻļā§āĻā§āϞāĻŋāϰ āĻļāĻā§āϤāĻŋāĻļāĻžāϞ⧠āϏāĻāĻā§āĻāύāĻāĻžāϰā§, āϝāĻž āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āĻā§ āϏāĻāĻā§āĻāĻŋāϤ āĻāϰā§āĨ¤
- āĻĒā§āϰāĻĻāĻžāĻš: āϤāĻžāϰāĻž āĻāĻāϏāĻŋāύā§āĻĢāĻŋāϞā§āϰ āĻŽāϤ⧠āĻĒā§āϰāĻĻāĻžāĻšāĻāύāĻ āĻā§āώāĻā§āϞāĻŋāĻā§ āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϤ⧠āĻāĻāϰā§āώāĻŖ āĻāϰā§, āϝāĻž āĻĻā§āϰā§āĻāĻŽā§āϝāĻŧāĻžāĻĻā§ āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϤ⧠āĻ āϤāĻŋ āϏāĻāĻŦā§āĻĻāύāĻļā§āϞāϤāĻž āĻāĻŦāĻ āĻĢā§āϞāĻžāĻāĻžāĻŦ āϏā§āώā§āĻāĻŋ āĻāϰā§āĨ¤
- āĻļā§āϞā§āώā§āĻŽāĻž āĻā§āĻĒāĻžāĻĻāύ āĻŦā§āĻĻā§āϧāĻŋ: āϞāĻŋāĻāĻā§āĻā§āϰāĻŋāϝāĻŧā§āύāϏ āĻļā§āϞā§āώā§āĻŽāĻž āύāĻŋāĻāϏāϰāĻŖāĻā§ āĻāĻĻā§āĻĻā§āĻĒāĻŋāϤ āĻāϰā§, āϝāĻž āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āĻā§ āĻāϰāĻ āĻŦāĻžāϧāĻžāĻā§āϰāϏā§āϤ āĻāϰāϤ⧠āĻĒāĻžāϰā§āĨ¤
- āϰāĻā§āϤāύāĻžāϞā§āϰ āĻĒā§āϰāĻŦā§āĻļāϝā§āĻā§āϝāϤāĻž āĻŦā§āĻĻā§āϧāĻŋ: āĻāĻā§āϞāĻŋ āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϰ āϰāĻā§āϤāύāĻžāϞā§āĻā§āϞāĻŋāĻā§ āĻāϰāĻ āĻĒā§āϰāĻŦā§āĻļāϝā§āĻā§āϝ āĻāϰ⧠āϤā§āϞā§, āϝāĻžāϰ āĻĢāϞ⧠āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϰ āĻĻā§āϝāĻŧāĻžāϞ⧠āĻĢā§āϞāĻžāĻāĻžāĻŦ (āĻāĻĄāĻŋāĻŽāĻž) āĻĻā§āĻāĻž āĻĻāĻŋāϤ⧠āĻĒāĻžāϰā§āĨ¤
- āĻŽāĻŋāĻāĻā§āϏāĻŋāϞāĻŋāϝāĻŧāĻžāϰāĻŋ āĻā§āϞāĻŋāϝāĻŧāĻžāϰā§āύā§āϏ āĻšā§āϰāĻžāϏ: āĻāĻ āĻĒā§āϰāĻāĻžāĻŦ āĻĢā§āϏāĻĢā§āϏā§āϰ āĻļā§āϞā§āώā§āĻŽāĻž āĻāĻŦāĻ āϧā§āĻŦāĻāϏāĻžāĻŦāĻļā§āώ āĻĒāϰāĻŋāώā§āĻāĻžāϰ āĻāϰāĻžāϰ āĻā§āώāĻŽāϤāĻžāĻā§ āĻŦā§āϝāĻžāĻšāϤ āĻāϰā§, āϝāĻžāϰ āĻĢāϞ⧠āĻļā§āĻŦāĻžāϏ-āĻĒā§āϰāĻļā§āĻŦāĻžāϏ āĻāϰāĻ āĻāĻ āĻŋāύ āĻšāϝāĻŧā§ āĻĒāĻĄāĻŧā§āĨ¤
āĻšāĻžāĻāĻĒāĻžāύāĻŋ āĻāĻā§āϰ⧠āϞāĻŋāĻāĻā§āĻā§āϰāĻŋāϝāĻŧā§āύāϏ
- āĻā§āϰāĻŋāĻāĻžāϰ: āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āĻāĻā§āϰāĻŽāĻŖā§āϰ āϏāĻŽāϝāĻŧ, āĻŽāĻžāϏā§āĻ āĻā§āώāĻā§āϞāĻŋ āϞāĻŋāĻāĻā§āĻā§āϰāĻŋāϝāĻŧā§āύ āύāĻŋāĻāϏāϰāĻŖ āĻāϰā§āĨ¤
- āĻā§āϰāĻŋāϝāĻŧāĻž: āĻāĻ āϞāĻŋāĻāĻā§āĻā§āϰāĻŋāϝāĻŧā§āύāĻā§āϞāĻŋ āϤāĻāύ āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϰ āĻŽāϏā§āĻŖ āĻĒā§āĻļā§ āϏāĻš āĻ āύā§āϝāĻžāύā§āϝ āĻā§āώā§āϰ āϰāĻŋāϏā§āĻĒā§āĻāϰā§āϰ āϏāĻžāĻĨā§ āĻāĻŦāĻĻā§āϧ āĻšāϝāĻŧāĨ¤
- āϞāĻā§āώāĻŖ: āĻāĻāĻŋ āĻŦā§āϰāĻā§āĻā§āĻāύāϏā§āĻā§āϰāĻŋāĻāĻļāύ, āĻĒā§āϰāĻĻāĻžāĻš āĻāĻŦāĻ āĻļā§āϞā§āώā§āĻŽāĻž āĻā§āĻĒāĻžāĻĻāύā§āϰ āĻĻāĻŋāĻā§ āĻĒāϰāĻŋāĻāĻžāϞāĻŋāϤ āĻāϰ⧠āĻāĻŽāύ āĻĒā§āϰāĻāĻžāĻŦā§āϰ āĻā§āϰāĻŽāĻŦāϰā§āϧāĻŽāĻžāύ āϏā§āϤā§āϰāĻĒāĻžāϤ āĻāϰā§, āϝāĻžāϰ āĻĢāϞ⧠āĻšāĻžāĻāĻĒāĻžāύāĻŋāϰ āĻāĻā§āϰāĻŽāĻŖ āĻšāϝāĻŧāĨ¤
- āĻĻā§āϰā§āĻāϏā§āĻĨāĻžāϝāĻŧā§ āĻšāĻžāĻāĻĒāĻžāύāĻŋ: āĻĻā§āϰā§āĻāϏā§āĻĨāĻžāϝāĻŧā§ āĻšāĻžāĻāĻĒāĻžāύāĻŋāϤā§, āϞāĻŋāĻāĻā§āĻā§āϰāĻŋāύāĻā§āϞāĻŋ āĻāĻāϏāĻŋāύā§āĻĢāĻŋāϞāĻā§āϞāĻŋāĻā§ āĻāĻāϰā§āώāĻŖ āĻāϰ⧠āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϰ āϏāĻžāϧāĻžāϰāĻŖ āĻšāĻžāĻāĻĒāĻžāϰāϰāϏā§āĻĒāύāϏāĻŋāĻāύā§āϏ⧠āĻ āĻŦāĻĻāĻžāύ āϰāĻžāĻāϤ⧠āĻĒāĻžāϰ⧠āϝāĻž āϞāĻŋāĻāĻā§āĻā§āϰāĻŋāύāĻ āϤā§āϰāĻŋ āĻāϰā§āĨ¤
How Prostaglandins cause Asthma?
Prostaglandins contribute to asthma
by causing inflammation and bronchoconstriction, with different types having opposing effects. For example, prostaglandin
D2cap D sub 2đˇ2 (
PGD2cap P cap G cap D sub 2đđēđˇ2), released by mast cells during an allergic reaction, triggers inflammatory cells to accumulate in the lungs, leading to the release of pro-inflammatory substances that worsen asthma symptoms. While prostaglandins like
PGE2cap P cap G cap E sub 2đđēđ¸2 can act as bronchodilators and reduce inflammation, the imbalance caused by an overproduction of other prostaglandins can lead to a “bronchospastic stimulus”.
Mechanisms of action
- Inflammation:
PGD2cap P cap G cap D sub 2đđēđˇ2 attracts and activates key immune cells like T helper 2 (
TH2cap T sub cap H 2đđģ2) cells and eosinophils, which release inflammatory cytokines and enzymes that damage lung tissue, cause mucus buildup, and lead to airway hyper-responsiveness.
- Bronchoconstriction: Some prostaglandins, like
PGFcap P cap G cap Fđđēđš compounds, act as bronchoconstrictors, causing the smooth muscles in the airways to tighten.
PGD2cap P cap G cap D sub 2đđēđˇ2 also has this effect, which narrows the airways and makes breathing difficult.
- Increased vascular permeability: Prostaglandins can increase blood flow and the permeability of blood vessels in the lungs, which leads to edema (swelling) that can further obstruct the airways.
- Imbalance of prostaglandins: The overall effect of prostaglandins is often a result of an imbalance. For example,
PGE2cap P cap G cap E sub 2đđēđ¸2 can have a protective effect by preventing bronchoconstriction from other triggers like histamine, but this balance can be upset in individuals with asthma.
Prostaglandins in different parts of the asthma cycle
- Asthma triggers: In an allergic reaction, mast cells are activated by allergens and release a cascade of mediators, including
PGD2cap P cap G cap D sub 2đđēđˇ2.
- Early response: The released prostaglandins contribute to the immediate bronchoconstriction and inflammation that characterize an asthma attack.
- Ongoing inflammation: The inflammatory cells recruited by prostaglandins continue to release inflammatory mediators, contributing to the chronic inflammation of the airways seen in asthma.
How to control mucus layer of Upper Respiratory Tract?
Controlling the mucus layer in the upper respiratory tract (URT) involves a combination of hydration, humidification, and lifestyle changes, along with over-the-counter or prescription medications if necessary. The primary goal is to keep the mucus thin and mobile so that the body’s natural defense mechanisms (like cilia and coughing) can clear it effectively.
Lifestyle and Home Remedies
These methods help maintain the normal function and hydration of the mucous membranes.
- Stay Hydrated:Â Drink plenty of fluids, especially water and warm liquids like broth or tea. Proper hydration keeps mucus thin and less sticky, making it easier to move and clear.
- Humidify the Air:Â Use a humidifier or steam vaporizer in your home, especially in the bedroom, to add moisture to dry air. Breathing moist air helps soothe irritated airways and keeps mucus from drying out. Inhaling steam from a hot shower or a bowl of hot water can also provide quick relief.
- Avoid Irritants:Â Steer clear of environmental irritants like smoke (including secondhand smoke), strong fragrances, chemicals, and pollution, which can irritate mucous membranes and trigger increased mucus production.
- Quit Smoking:Â Smoking paralyzes the cilia (tiny hair-like cells that move mucus out of the airways) and causes the body to produce thicker, more abundant mucus. Quitting smoking is one of the most effective ways to restore normal mucus function.
- Elevate Your Head:Â Sleeping with your head propped up on pillows can help prevent mucus from pooling in the back of your throat.
- Gargle with Salt Water:Â Gargling with warm salt water can help clear mucus from the back of the throat and soothe irritation.
- Use Saline Nasal Rinses: A saline nasal spray or a neti pot can flush mucus and allergens out of your nasal passages and sinuses.Â
Airway Clearance Techniques
For stubborn or excess mucus, specific techniques can aid removal:
- Controlled Coughing/Huffing:Â Instead of harsh, uncontrolled coughing, try “huff coughing.” Inhale deeply, tense your stomach muscles, and exhale quickly in three short bursts, making a “ha” sound. This helps move mucus from smaller airways to larger ones where it can be coughed up more effectively.
- Physical Exercise:Â Regular physical activity increases breathing rate and air flow, which can help loosen and move mucus out of the lungs and airways.Â
Medications
Over-the-counter (OTC) and prescription options are available to manage excessive mucus:
- Expectorants: OTC medications containing guaifenesin (e.g., Mucinex) thin and loosen mucus, making it easier to cough up.
- Mucolytics:Â These drugs, such as hypertonic saline (inhaled via a nebulizer) or dornase alfa (prescription for chronic conditions like cystic fibrosis), directly break down the chemical bonds within mucus to reduce its viscosity.
- Antihistamines/Decongestants:Â If excess mucus is due to allergies, antihistamines can help. However, some decongestants may dry secretions too much, making mucus difficult to expel, so use with caution and consult a healthcare provider.
- Bronchodilators:Â For conditions like asthma or COPD, a doctor may prescribe bronchodilators to open the airways, which can also improve mucus clearance.Â
When to See a Doctor
While most cases of excess mucus are manageable with home care, consult a healthcare professional if:
- You experience a significant increase in mucus production or a change in its color (green or yellow), which may indicate an infection.
- Your cough lasts for more than a couple of weeks.
- You have difficulty breathing, chest pain, or bloody mucus.Â
Addressing the underlying cause, whether it’s an infection, allergies, or a chronic condition, is crucial for effective long-term control.
āĻāĻĒāϰā§āϰ āĻļā§āĻŦāĻžāϏ āύāĻžāϞā§āϰ (URT) āĻļā§āϞā§āώā§āĻŽāĻž āϏā§āϤāϰ āύāĻŋāϝāĻŧāύā§āϤā§āϰāĻŖā§āϰ āĻāύā§āϝ āĻšāĻžāĻāĻĄā§āϰā§āĻļāύ, āĻāϰā§āĻĻā§āϰāϤāĻž āĻāĻŦāĻ āĻā§āĻŦāύāϝāĻžāϤā§āϰāĻžāϰ āĻĒāϰāĻŋāĻŦāϰā§āϤāύā§āϰāϏāĻŽāύā§āĻŦāϝāĻŧ āĻĒā§āϰāϝāĻŧā§āĻāύ , āϏā§āĻ āϏāĻžāĻĨā§ āĻĒā§āϰāϝāĻŧā§āĻāύ⧠āĻāĻāĻžāϰ-āĻĻā§āϝ-āĻāĻžāĻāύā§āĻāĻžāϰ āĻŦāĻž āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ āĻāώā§āϧāĻ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰāĻž āĻšāϝāĻŧāĨ¤ āĻĒā§āϰāĻžāĻĨāĻŽāĻŋāĻ āϞāĻā§āώā§āϝ āĻšāϞ āĻļā§āϞā§āώā§āĻŽāĻžāĻā§ āĻĒāĻžāϤāϞāĻž āĻāĻŦāĻ āϏāĻāϞ āϰāĻžāĻāĻž āϝāĻžāϤ⧠āĻļāϰā§āϰā§āϰ āĻĒā§āϰāĻžāĻā§āϤāĻŋāĻ āĻĒā§āϰāϤāĻŋāϰāĻā§āώāĻž āĻŦā§āϝāĻŦāϏā§āĻĨāĻž (āϝā§āĻŽāύ āϏāĻŋāϞāĻŋāϝāĻŧāĻž āĻāĻŦāĻ āĻāĻžāĻļāĻŋ) āĻāĻžāϰā§āϝāĻāϰāĻāĻžāĻŦā§ āĻāĻāĻŋ āĻĒāϰāĻŋāώā§āĻāĻžāϰ āĻāϰāϤ⧠āĻĒāĻžāϰā§āĨ¤
āĻā§āĻŦāύāϧāĻžāϰāĻž āĻāĻŦāĻ āĻāϰā§āϝāĻŧāĻž āĻĒā§āϰāϤāĻŋāĻāĻžāϰ
āĻāĻ āĻĒāĻĻā§āϧāϤāĻŋāĻā§āϞāĻŋ āĻļā§āϞā§āώā§āĻŽāĻž āĻāĻŋāϞā§āϞāĻŋāϰ āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻ āĻāĻžāϰā§āϝāĻāĻžāϰāĻŋāϤāĻž āĻāĻŦāĻ āĻšāĻžāĻāĻĄā§āϰā§āĻļāύ āĻŦāĻāĻžāϝāĻŧ āϰāĻžāĻāϤ⧠āϏāĻžāĻšāĻžāϝā§āϝ āĻāϰā§āĨ¤
- āĻšāĻžāĻāĻĄā§āϰā§āĻā§āĻĄ āĻĨāĻžāĻā§āύ: āĻĒā§āϰāĻā§āϰ āĻĒāϰāĻŋāĻŽāĻžāĻŖā§ āϤāϰāϞ āĻĒāĻžāύ āĻāϰā§āύ, āĻŦāĻŋāĻļā§āώ āĻāϰ⧠āĻāϞ āĻāĻŦāĻ āĻā§āϞ āĻŦāĻž āĻāĻž āĻāϰ āĻŽāϤ⧠āĻāώā§āĻŖ āϤāϰāϞ āĻĒāĻžāύ āĻāϰā§āύāĨ¤ āϏāĻ āĻŋāĻ āĻšāĻžāĻāĻĄā§āϰā§āĻļāύ āĻļā§āϞā§āώā§āĻŽāĻžāĻā§ āĻĒāĻžāϤāϞāĻž āĻāĻŦāĻ āĻāĻŽ āĻāĻ āĻžāϞ⧠āϰāĻžāĻā§, āϝāĻž āĻāϞāĻžāĻāϞ āĻāĻŦāĻ āĻĒāϰāĻŋāώā§āĻāĻžāϰ āĻāϰāĻž āϏāĻšāĻ āĻāϰ⧠āϤā§āϞā§āĨ¤
- āĻŦāĻžāϤāĻžāϏāĻā§ āĻāϰā§āĻĻā§āϰ āĻāϰā§āύ: āĻļā§āώā§āĻ āĻŦāĻžāϤāĻžāϏ⧠āĻāϰā§āĻĻā§āϰāϤāĻž āϝā§āĻ āĻāϰāϤ⧠āĻāĻĒāύāĻžāϰ āĻŦāĻžāĻĄāĻŧāĻŋāϤā§, āĻŦāĻŋāĻļā§āώ āĻāϰ⧠āĻļā§āĻŦāĻžāϰ āĻāϰā§, āĻāĻāĻāĻŋ āĻšāĻŋāĻāĻŽāĻŋāĻĄāĻŋāĻĢāĻžāϝāĻŧāĻžāϰ āĻŦāĻž āϏā§āĻāĻŋāĻŽ āĻā§āϝāĻžāĻĒā§āϰāĻžāĻāĻāĻžāϰ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰā§āύāĨ¤ āĻāϰā§āĻĻā§āϰ āĻŦāĻžāϤāĻžāϏ āĻļā§āĻŦāĻžāϏ āύā§āĻāϝāĻŧāĻž āĻā§āĻŦāĻžāϞāĻžāĻĒā§āĻĄāĻŧāĻž āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āĻā§ āĻĒā§āϰāĻļāĻŽāĻŋāϤ āĻāϰāϤ⧠āϏāĻžāĻšāĻžāϝā§āϝ āĻāϰ⧠āĻāĻŦāĻ āĻļā§āϞā§āώā§āĻŽāĻž āĻļā§āĻāĻŋāϝāĻŧā§ āϝāĻžāĻāϝāĻŧāĻž āĻĨā§āĻā§ āϰāĻā§āώāĻž āĻāϰā§āĨ¤ āĻāϰāĻŽ āĻļāĻžāĻāϝāĻŧāĻžāϰ āĻŦāĻž āĻāϰāĻŽ āĻāϞā§āϰ āĻŦāĻžāĻāĻŋ āĻĨā§āĻā§ āĻŦāĻžāώā§āĻĒ āĻļā§āĻŦāĻžāϏ āύā§āĻāϝāĻŧāĻžāϰ āĻŽāĻžāϧā§āϝāĻŽā§āĻ āĻĻā§āϰā§āϤ āĻāϰāĻžāĻŽ āĻĒāĻžāĻāϝāĻŧāĻž āϝā§āϤ⧠āĻĒāĻžāϰā§āĨ¤
- āĻā§āĻŦāĻžāϞāĻžāĻĒā§āĻĄāĻŧāĻž āĻāĻĄāĻŧāĻŋāϝāĻŧā§ āĻāϞā§āύ: āĻĒāϰāĻŋāĻŦā§āĻļāĻāϤ āĻā§āĻŦāĻžāϞāĻžāĻĒā§āĻĄāĻŧāĻž āϝā§āĻŽāύ āϧā§āĻāϝāĻŧāĻž (āĻĒāϰāĻŦāϰā§āϤ⧠āϧā§āĻāϝāĻŧāĻž āϏāĻš), āϤā§āĻŦā§āϰ āϏā§āĻāύā§āϧāĻŋ, āϰāĻžāϏāĻžāϝāĻŧāύāĻŋāĻ āĻāĻŦāĻ āĻĻā§āώāĻŖ āĻĨā§āĻā§ āĻĻā§āϰ⧠āĻĨāĻžāĻā§āύ, āϝāĻž āĻļā§āϞā§āώā§āĻŽāĻž āĻāĻŋāϞā§āϞāĻŋāĻā§ āĻā§āĻŦāĻžāϞāĻžāĻĒā§āĻĄāĻŧāĻž āĻāϰāϤ⧠āĻĒāĻžāϰ⧠āĻāĻŦāĻ āĻļā§āϞā§āώā§āĻŽāĻž āĻā§āĻĒāĻžāĻĻāύ āĻŦā§āĻĻā§āϧāĻŋ āĻāϰāϤ⧠āĻĒāĻžāϰā§āĨ¤
- āϧā§āĻŽāĻĒāĻžāύ āϤā§āϝāĻžāĻ āĻāϰā§āύ: āϧā§āĻŽāĻĒāĻžāύ āϏāĻŋāϞāĻŋāϝāĻŧāĻž (āĻā§āĻ āĻā§āϞā§āϰ āĻŽāϤ⧠āĻā§āώ āϝāĻž āĻļā§āĻŦāĻžāϏāύāĻžāϞ⧠āĻĨā§āĻā§ āĻļā§āϞā§āώā§āĻŽāĻž āĻŦā§āϰ āĻāϰ⧠āĻĻā§āϝāĻŧ) āĻĒāĻā§āώāĻžāĻāĻžāϤāĻā§āϰāϏā§āϤ āĻāϰ⧠āĻāĻŦāĻ āĻļāϰā§āϰāĻā§ āĻāύ, āĻāϰāĻ āĻĒā§āϰāĻā§āϰ āĻĒāϰāĻŋāĻŽāĻžāĻŖā§ āĻļā§āϞā§āώā§āĻŽāĻž āϤā§āϰāĻŋ āĻāϰāϤ⧠āĻŦāĻžāϧā§āϝ āĻāϰā§āĨ¤ āĻļā§āϞā§āώā§āĻŽāĻž āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻ āĻāĻžāϰā§āϝāĻāĻžāϰāĻŋāϤāĻž āĻĒā§āύāϰā§āĻĻā§āϧāĻžāϰā§āϰ āϏāĻŦāĻā§āϝāĻŧā§ āĻāĻžāϰā§āϝāĻāϰ āĻāĻĒāĻžāϝāĻŧāĻā§āϞāĻŋāϰ āĻŽāϧā§āϝ⧠āĻāĻāĻāĻŋ āĻšāϞ āϧā§āĻŽāĻĒāĻžāύ āϤā§āϝāĻžāĻ āĻāϰāĻžāĨ¤
- āĻŽāĻžāĻĨāĻž āĻāĻāĻā§ āĻāϰā§āύ: āĻŦāĻžāϞāĻŋāĻļā§ āĻŽāĻžāĻĨāĻž āϰā§āĻā§ āĻā§āĻŽāĻžāϞ⧠āĻāϞāĻžāϰ āĻĒā§āĻāύ⧠āĻļā§āϞā§āώā§āĻŽāĻž āĻāĻŽāĻž āĻšāĻāϝāĻŧāĻž āϰā§āϧ āĻāϰāĻž āϝāĻžāϝāĻŧāĨ¤
- āϞāĻŦāĻŖ āĻĒāĻžāύāĻŋ āĻĻāĻŋāϝāĻŧā§ āĻāĻžāϰā§āĻāϞ āĻāϰā§āύ: āĻāώā§āĻŖ āϞāĻŦāĻŖ āĻĒāĻžāύāĻŋ āĻĻāĻŋāϝāĻŧā§ āĻāĻžāϰā§āĻāϞ āĻāϰāϞ⧠āĻāϞāĻžāϰ āĻĒā§āĻāύ āĻĨā§āĻā§ āĻļā§āϞā§āώā§āĻŽāĻž āĻĒāϰāĻŋāώā§āĻāĻžāϰ āĻšāϤ⧠āĻĒāĻžāϰ⧠āĻāĻŦāĻ āĻā§āĻŦāĻžāϞāĻž āĻĒā§āϰāĻļāĻŽāĻŋāϤ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤
- āϏā§āϝāĻžāϞāĻžāĻāύ āύāĻžāϏāĻžāϞ āϰāĻŋāύā§āϏ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰā§āύ: āϏā§āϝāĻžāϞāĻžāĻāύ āύāĻžāϏāĻžāϞ āϏā§āĻĒā§āϰ⧠āĻŦāĻžÂ āύā§āĻāĻŋ āĻĒāĻ āĻāĻĒāύāĻžāϰ āύāĻžāĻā§āϰ āĻĒāĻĨ āĻāĻŦāĻ āϏāĻžāĻāύāĻžāϏ āĻĨā§āĻā§ āĻļā§āϞā§āώā§āĻŽāĻž āĻāĻŦāĻ āĻ ā§āϝāĻžāϞāĻžāϰā§āĻā§āύ āĻŦā§āϰ āĻāϰ⧠āĻĻāĻŋāϤ⧠āĻĒāĻžāϰā§āĨ¤Â
āĻāϝāĻŧāĻžāϰāĻāϝāĻŧā§ āĻā§āϞāĻŋāϝāĻŧāĻžāϰā§āύā§āϏ āĻā§āĻļāϞ
āĻāĻāĻā§āĻāϝāĻŧā§ āĻŦāĻž āĻ āϤāĻŋāϰāĻŋāĻā§āϤ āĻļā§āϞā§āώā§āĻŽāĻž āĻ āĻĒāϏāĻžāϰāĻŖā§, āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āĻā§āĻļāϞāĻā§āϞāĻŋ āϏāĻžāĻšāĻžāϝā§āϝ āĻāϰāϤ⧠āĻĒāĻžāϰā§:
- āύāĻŋāϝāĻŧāύā§āϤā§āϰāĻŋāϤ āĻāĻžāĻļāĻŋ/āĻšāĻžāĻĢāĻŋāĻ: āϤā§āĻŦā§āϰ, āĻ āύāĻŋāϝāĻŧāύā§āϤā§āϰāĻŋāϤ āĻāĻžāĻļāĻŋāϰ āĻĒāϰāĻŋāĻŦāϰā§āϤā§, “āĻšāĻžāĻĢāĻŋāĻ āĻāĻžāĻļāĻŋ” āĻā§āώā§āĻāĻž āĻāϰā§āύāĨ¤ āĻāĻā§āϰāĻāĻžāĻŦā§ āĻļā§āĻŦāĻžāϏ āύāĻŋāύ, āĻāĻĒāύāĻžāϰ āĻĒā§āĻā§āϰ āĻĒā§āĻļā§āĻā§āϞāĻŋāĻā§ āĻāĻžāύ āĻĻāĻŋāύ āĻāĻŦāĻ “āĻšāĻž” āĻļāĻŦā§āĻĻ āĻāϰ⧠āϤāĻŋāύāĻāĻŋ āĻā§āĻ āĻŦāĻŋāϏā§āĻĢā§āϰāĻŖā§ āĻĻā§āϰā§āϤ āĻļā§āĻŦāĻžāϏ āĻāĻžāĻĄāĻŧā§āύāĨ¤ āĻāĻāĻŋ āĻā§āĻ āĻļā§āĻŦāĻžāϏāύāĻžāϞ⧠āĻĨā§āĻā§ āĻŦā§āĻšāϤā§āϤāϰ āĻļā§āĻŦāĻžāϏāύāĻžāϞā§āϤ⧠āĻļā§āϞā§āώā§āĻŽāĻž āϏā§āĻĨāĻžāύāĻžāύā§āϤāϰ āĻāϰāϤ⧠āϏāĻžāĻšāĻžāϝā§āϝ āĻāϰ⧠āϝā§āĻāĻžāύ⧠āĻāĻāĻŋ āĻāϰāĻ āĻāĻžāϰā§āϝāĻāϰāĻāĻžāĻŦā§ āĻāĻžāĻļāĻŋ āĻĻā§āĻāϝāĻŧāĻž āϝā§āϤ⧠āĻĒāĻžāϰā§āĨ¤
- āĻļāĻžāϰā§āϰāĻŋāĻ āĻŦā§āϝāĻžāϝāĻŧāĻžāĻŽ: āύāĻŋāϝāĻŧāĻŽāĻŋāϤ āĻļāĻžāϰā§āϰāĻŋāĻ āĻāĻžāϰā§āϝāĻāϞāĻžāĻĒ āĻļā§āĻŦāĻžāϏ-āĻĒā§āϰāĻļā§āĻŦāĻžāϏā§āϰ āĻšāĻžāϰ āĻāĻŦāĻ āĻŦāĻžāϤāĻžāϏā§āϰ āĻĒā§āϰāĻŦāĻžāĻš āĻŦā§āĻĻā§āϧāĻŋ āĻāϰā§, āϝāĻž āĻĢā§āϏāĻĢā§āϏ āĻāĻŦāĻ āĻļā§āĻŦāĻžāϏāύāĻžāϞ⧠āĻĨā§āĻā§ āĻļā§āϞā§āώā§āĻŽāĻž āĻāϞāĻāĻž āĻāϰāϤ⧠āĻāĻŦāĻ āĻŦā§āϰ āĻāϰ⧠āĻĻāĻŋāϤ⧠āϏāĻžāĻšāĻžāϝā§āϝ āĻāϰā§āĨ¤Â
āĻāώā§āϧ
āĻ āϤāĻŋāϰāĻŋāĻā§āϤ āĻļā§āϞā§āώā§āĻŽāĻž āύāĻŋāϝāĻŧāύā§āϤā§āϰāĻŖā§āϰ āĻāύā§āϝ āĻāĻāĻžāϰ-āĻĻā§āϝ-āĻāĻžāĻāύā§āĻāĻžāϰ (OTC) āĻāĻŦāĻ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύā§āϰ āĻŦāĻŋāĻāϞā§āĻĒāĻā§āϞāĻŋ āĻĒāĻžāĻāϝāĻŧāĻž āϝāĻžāϝāĻŧ:
- āĻāĻĢā§āϰ āĻāώāϧ:āĻā§āϝāĻŧāĻžāĻāĻĢā§āύā§āϏāĻŋāĻ¨Â (āϝā§āĻŽāύ, āĻŽāĻŋāĻāϏāĻŋāύā§āĻā§āĻ¸Â ) āϧāĻžāϰāĻŖāĻāĻžāϰ⧠āĻāĻāĻŋāϏāĻŋ āĻāώā§āĻ§Â āĻļā§āϞā§āώā§āĻŽāĻž āĻĒāĻžāϤāϞāĻž āĻāĻŦāĻ āĻāϞāĻāĻž āĻāϰā§, āϝāĻžāϰ āĻĢāϞ⧠āĻāĻžāĻļāĻŋ āϏāĻšāĻ āĻšāϝāĻŧāĨ¤
- āĻŽāĻŋāĻāĻā§āϞāĻžāĻāĻāĻŋāĻā§āϏ: āĻāĻ āĻāώā§āϧāĻā§āϞāĻŋ, āϝā§āĻŽāύ āĻšāĻžāĻāĻĒāĻžāϰāĻā§āύāĻŋāĻ āϏā§āϝāĻžāϞāĻžāĻāύ (āύā§āĻŦā§āϞāĻžāĻāĻāĻžāϰā§āϰ āĻŽāĻžāϧā§āϝāĻŽā§ āĻļā§āĻŦāĻžāϏ āύā§āĻāϝāĻŧāĻž) āĻŦāĻž āĻĄā§āϰāύā§āϏ āĻāϞāĻĢāĻž (āϏāĻŋāϏā§āĻāĻŋāĻ āĻĢāĻžāĻāĻŦā§āϰā§āϏāĻŋāϏā§āϰ āĻŽāϤ⧠āĻĻā§āϰā§āĻāϏā§āĻĨāĻžāϝāĻŧā§ āĻ āĻŦāϏā§āĻĨāĻžāϰ āĻāύā§āϝ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ), āĻļā§āϞā§āώā§āĻŽāĻžāϰ āϏāĻžāύā§āĻĻā§āϰāϤāĻž āĻāĻŽāĻžāϤ⧠āϏāϰāĻžāϏāϰāĻŋ āϰāĻžāϏāĻžāϝāĻŧāύāĻŋāĻ āĻŦāύā§āϧāύ āĻā§āĻā§ āĻĻā§āϝāĻŧāĨ¤
- āĻ ā§āϝāĻžāύā§āĻāĻŋāĻšāĻŋāϏā§āĻāĻžāĻŽāĻžāĻāύ/āĻĄāĻŋāĻāύāĻā§āϏā§āĻā§āϝāĻžāύā§āĻ: āϝāĻĻāĻŋ āĻ ā§āϝāĻžāϞāĻžāϰā§āĻāĻŋāϰ āĻāĻžāϰāĻŖā§ āĻ āϤāĻŋāϰāĻŋāĻā§āϤ āĻļā§āϞā§āώā§āĻŽāĻž āĻšāϝāĻŧ, āϤāĻžāĻšāϞ⧠āĻ ā§āϝāĻžāύā§āĻāĻŋāĻšāĻŋāϏā§āĻāĻžāĻŽāĻžāĻāύ āϏāĻžāĻšāĻžāϝā§āϝ āĻāϰāϤ⧠āĻĒāĻžāϰā§āĨ¤ āϤāĻŦā§, āĻāĻŋāĻā§ āĻĄāĻŋāĻāύāĻā§āϏā§āĻā§āϝāĻžāύā§āĻ āϏā§āϰāĻžāĻŦāĻā§ āĻā§āĻŦ āĻŦā§āĻļāĻŋ āĻļā§āĻāĻŋāϝāĻŧā§ āĻĻāĻŋāϤ⧠āĻĒāĻžāϰā§, āϝāĻžāϰ āĻĢāϞ⧠āĻļā§āϞā§āώā§āĻŽāĻž āĻŦā§āϰ āĻāϰāĻž āĻāĻ āĻŋāύ āĻšāϝāĻŧā§ āĻĒāĻĄāĻŧā§, āϤāĻžāĻ āϏāĻžāĻŦāϧāĻžāύāϤāĻžāϰ āϏāĻžāĻĨā§ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰā§āύ āĻāĻŦāĻ āĻāĻāĻāύ āϏā§āĻŦāĻžāϏā§āĻĨā§āϝāϏā§āĻŦāĻž āĻĒā§āϰāĻĻāĻžāύāĻāĻžāϰā§āϰ āϏāĻžāĻĨā§ āĻĒāϰāĻžāĻŽāϰā§āĻļ āĻāϰā§āύāĨ¤
- āĻŦā§āϰāĻā§āĻā§āĻĄāĻžāĻāϞā§āĻāϰ: āĻšāĻžāĻāĻĒāĻžāύāĻŋ āĻŦāĻž āϏāĻŋāĻāĻĒāĻŋāĻĄāĻŋāϰ āĻŽāϤ⧠āĻ āĻŦāϏā§āĻĨāĻžāϰ āĻāύā§āϝ, āĻāĻāĻāύ āĻĄāĻžāĻā§āϤāĻžāϰ āĻļā§āĻŦāĻžāϏāύāĻžāϞ⧠āĻā§āϞāĻžāϰ āĻāύā§āϝ āĻŦā§āϰāĻā§āĻā§āĻĄāĻžāĻāϞā§āĻāϰ āϞāĻŋāĻā§ āĻĻāĻŋāϤ⧠āĻĒāĻžāϰā§āύ, āϝāĻž āĻļā§āϞā§āώā§āĻŽāĻž āύāĻŋāώā§āĻāĻžāĻļāύāĻā§āĻ āĻāύā§āύāϤ āĻāϰāϤ⧠āĻĒāĻžāϰā§āĨ¤Â
āĻāĻāύ āĻĄāĻžāĻā§āϤāĻžāϰā§āϰ āϏāĻžāĻĨā§ āĻĻā§āĻāĻž āĻāϰāĻŦā§āύ
āϝāĻĻāĻŋāĻ āĻ āϤāĻŋāϰāĻŋāĻā§āϤ āĻļā§āϞā§āώā§āĻŽāĻž āĻšāĻāϝāĻŧāĻžāϰ āĻŦā§āĻļāĻŋāϰāĻāĻžāĻ āĻā§āώā§āϤā§āϰā§āĻ āĻāϰā§āϝāĻŧāĻž āĻāĻŋāĻāĻŋā§āϏāĻžāϰ āĻŽāĻžāϧā§āϝāĻŽā§ āύāĻŋāϝāĻŧāύā§āϤā§āϰāĻŖ āĻāϰāĻž āϏāĻŽā§āĻāĻŦ, āϤāĻŦā§ āύāĻŋāĻŽā§āύāϞāĻŋāĻāĻŋāϤ āĻā§āώā§āϤā§āϰ⧠āĻāĻāĻāύ āϏā§āĻŦāĻžāϏā§āĻĨā§āϝāϏā§āĻŦāĻž āĻĒā§āĻļāĻžāĻĻāĻžāϰā§āϰ āϏāĻžāĻĨā§ āĻĒāϰāĻžāĻŽāϰā§āĻļ āĻāϰā§āύ:
- āĻāĻĒāύāĻžāϰ āĻļā§āϞā§āώā§āĻŽāĻž āĻā§āĻĒāĻžāĻĻāύ⧠āĻāϞā§āϞā§āĻāϝā§āĻā§āϝ āĻŦā§āĻĻā§āϧāĻŋ āĻŦāĻž āĻāϰ āϰāĻ (āϏāĻŦā§āĻ āĻŦāĻž āĻšāϞā§āĻĻ) āĻĒāϰāĻŋāĻŦāϰā§āϤāύ āĻ āύā§āĻāĻŦ āĻāϰāĻž āĻāĻāĻŋāϤ, āϝāĻž āϏāĻāĻā§āϰāĻŽāĻŖā§āϰ āĻāĻā§āĻāĻŋāϤ āĻĻāĻŋāϤ⧠āĻĒāĻžāϰā§āĨ¤
- āĻāĻĒāύāĻžāϰ āĻāĻžāĻļāĻŋ āĻāϝāĻŧā§āĻ āϏāĻĒā§āϤāĻžāĻšā§āϰāĻ āĻŦā§āĻļāĻŋ āϏāĻŽāϝāĻŧ āϧāϰ⧠āĻĨāĻžāĻā§āĨ¤
- āĻāĻĒāύāĻžāϰ āĻļā§āĻŦāĻžāϏ āύāĻŋāϤ⧠āĻāώā§āĻ āĻšāĻā§āĻā§, āĻŦā§āĻā§ āĻŦā§āϝāĻĨāĻž āĻšāĻā§āĻā§, āĻ āĻĨāĻŦāĻž āϰāĻā§āϤāĻžāĻā§āϤ āĻļā§āϞā§āώā§āĻŽāĻž āĻšāĻā§āĻā§āĨ¤Â
āĻĻā§āϰā§āĻāĻŽā§āϝāĻŧāĻžāĻĻā§ āĻāĻžāϰā§āϝāĻāϰ āύāĻŋāϝāĻŧāύā§āϤā§āϰāĻŖā§āϰ āĻāύā§āϝ, āĻ āύā§āϤāϰā§āύāĻŋāĻšāĻŋāϤ āĻāĻžāϰāĻŖ, āϤāĻž āϏ⧠āϏāĻāĻā§āϰāĻŽāĻŖ, āĻ ā§āϝāĻžāϞāĻžāϰā§āĻāĻŋ āĻŦāĻž āĻĻā§āϰā§āĻāϏā§āĻĨāĻžāϝāĻŧā§ āĻ āĻŦāϏā§āĻĨāĻž āϝāĻžāĻ āĻšā§āĻ āύāĻž āĻā§āύ, āϤāĻžāϰ āϏāĻŽāĻžāϧāĻžāύ āĻāϰāĻž āĻ āϤā§āϝāύā§āϤ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖāĨ¤
What is Neti pot?
A neti pot is a nasal irrigation device, resembling a small teapot, that uses a saline (saltwater) solution to rinse mucus and debris from the nasal passages. It is used to relieve congestion from colds, allergies, and sinus infections, as well as to moisturize nasal passages from dry air. Proper and safe use requires using sterile, distilled, or previously boiled water to avoid serious infection.Â
How a neti pot works
- Flushes out mucus:Â You tilt your head and pour the saline solution from the neti pot spout into one nostril.
- Flows through nasal cavity:Â The solution flows through the nasal cavity and drains out of the other nostril.
- Relieves symptoms:Â This helps to clear out allergens, dust, and loose mucus, reducing symptoms like a stuffy nose and sinus pressure.Â
Safety and usage tips
- Use safe water:Â Always use distilled, sterile, or previously boiled and cooled water to prevent the risk of serious infections.
- Clean the device:Â Thoroughly wash and dry the neti pot after each use.
- Wash hands:Â Wash and dry your hands before and after using the device.
- Consult a doctor:Â Talk to a healthcare provider before using a neti pot, especially if you have a compromised immune system or have had recent nasal surgery.
- Make your own solution:Â You can make a saline solution by mixing non-iodized powdered salt with boiled water, but make a fresh batch each time.Â
āύā§āĻāĻŋ āĻĒāĻ āĻšāĻ˛Â āĻāĻāĻāĻŋ āύāĻžāĻ āϏā§āĻā§āϰ āϝāύā§āϤā§āϰ, āϝāĻž āĻāĻāĻāĻŋ āĻā§āĻ āĻāĻžāϝāĻŧā§āϰ āĻĒāĻžāϤā§āϰā§āϰ āĻŽāϤā§, āϝāĻž āϞāĻŦāĻŖāĻžāĻā§āϤ (āϞāĻŦāĻŖ āĻāϞ) āĻĻā§āϰāĻŦāĻŖ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰ⧠āύāĻžāĻā§āϰ āĻļā§āϞā§āώā§āĻŽāĻž āĻāĻŦāĻ āϧā§āĻŦāĻāϏāĻžāĻŦāĻļā§āώ āϧā§āϝāĻŧā§ āĻĢā§āϞāĻž āĻšāϝāĻŧāĨ¤āĻāĻāĻŋ āϏāϰā§āĻĻāĻŋ, āĻ ā§āϝāĻžāϞāĻžāϰā§āĻāĻŋ āĻāĻŦāĻ āϏāĻžāĻāύāĻžāϏā§āϰ āϏāĻāĻā§āϰāĻŽāĻŖ āĻĨā§āĻā§ āϰāĻā§āϤāĻā§āώāϰāĻŖ āĻĻā§āϰ āĻāϰāϤ⧠āĻāĻŦāĻ āĻļā§āώā§āĻ āĻŦāĻžāϤāĻžāϏ āĻĨā§āĻā§ āύāĻžāĻāĻā§ āĻāϰā§āĻĻā§āϰ āĻāϰāϤ⧠āĻŦā§āϝāĻŦāĻšā§āϤ āĻšāϝāĻŧāĨ¤ āĻā§āϰā§āϤāϰ āϏāĻāĻā§āϰāĻŽāĻŖ āĻāĻĄāĻŧāĻžāϤ⧠āϏāĻ āĻŋāĻ āĻāĻŦāĻ āύāĻŋāϰāĻžāĻĒāĻĻ āĻŦā§āϝāĻŦāĻšāĻžāϰā§āϰ āĻāύā§āϝ āĻā§āĻŦāĻžāĻŖā§āĻŽā§āĻā§āϤ, āĻĒāĻžāϤāĻŋāϤ āĻŦāĻž āĻĒā§āϰā§āĻŦā§ āĻĢā§āĻāĻžāύ⧠āĻāϞ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰāĻž āĻĒā§āϰāϝāĻŧā§āĻāύāĨ¤Â
āύā§āĻāĻŋ āĻĒāĻ āĻā§āĻāĻžāĻŦā§ āĻāĻžāĻ āĻāϰā§
- āĻļā§āϞā§āώā§āĻŽāĻž āĻŦā§āϰ āĻāϰ⧠āĻĻā§āϝāĻŧ: āĻāĻĒāύāĻŋ āĻāĻĒāύāĻžāϰ āĻŽāĻžāĻĨāĻž āĻāĻžāϤ āĻāϰ⧠āύā§āĻāĻŋ āĻĒāĻ āϏā§āĻĒāĻžāĻāĻ āĻĨā§āĻā§ āϏā§āϝāĻžāϞāĻžāĻāύā§āϰ āĻĻā§āϰāĻŦāĻŖ āĻāĻāĻāĻŋ āύāĻžāĻā§āϰ āĻāĻŋāĻĻā§āϰ⧠āĻĸā§āϞ⧠āĻĻāĻŋāύāĨ¤
- āύāĻžāĻā§āϰ āĻāĻšā§āĻŦāϰā§āϰ āĻŽāϧā§āϝ āĻĻāĻŋāϝāĻŧā§ āĻĒā§āϰāĻŦāĻžāĻšāĻŋāϤ āĻšāϝāĻŧ: āĻĻā§āϰāĻŦāĻŖāĻāĻŋ āύāĻžāĻā§āϰ āĻāĻšā§āĻŦāϰā§āϰ āĻŽāϧā§āϝ āĻĻāĻŋāϝāĻŧā§ āĻĒā§āϰāĻŦāĻžāĻšāĻŋāϤ āĻšāϝāĻŧ āĻāĻŦāĻ āĻ āύā§āϝ āύāĻžāĻā§āϰ āĻāĻŋāĻĻā§āϰ āĻĻāĻŋāϝāĻŧā§ āĻŦā§āϰāĻŋāϝāĻŧā§ āϝāĻžāϝāĻŧāĨ¤
- āϞāĻā§āώāĻŖāĻā§āϞāĻŋ āĻāĻĒāĻļāĻŽ āĻāϰā§: āĻāĻāĻŋ āĻ ā§āϝāĻžāϞāĻžāϰā§āĻā§āύ, āϧā§āϞ⧠āĻāĻŦāĻ āĻāϞāĻāĻž āĻļā§āϞā§āώā§āĻŽāĻž āĻĒāϰāĻŋāώā§āĻāĻžāϰ āĻāϰāϤ⧠āϏāĻžāĻšāĻžāϝā§āϝ āĻāϰā§, āϝāĻž āύāĻžāĻ āĻŦāύā§āϧ āĻšāϝāĻŧā§ āϝāĻžāĻāϝāĻŧāĻž āĻāĻŦāĻ āϏāĻžāĻāύāĻžāϏā§āϰ āĻāĻžāĻĒā§āϰ āĻŽāϤ⧠āϞāĻā§āώāĻŖāĻā§āϞāĻŋ āĻšā§āϰāĻžāϏ āĻāϰā§āĨ¤Â
āύāĻŋāϰāĻžāĻĒāϤā§āϤāĻž āĻāĻŦāĻ āĻŦā§āϝāĻŦāĻšāĻžāϰā§āϰ āĻāĻŋāĻĒāϏ
- āύāĻŋāϰāĻžāĻĒāĻĻ āĻĒāĻžāύāĻŋ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰā§āύ: āĻā§āϰā§āϤāϰ āϏāĻāĻā§āϰāĻŽāĻŖā§āϰ āĻā§āĻāĻāĻŋ āĻāĻĄāĻŧāĻžāϤ⧠āϏāϰā§āĻŦāĻĻāĻž āĻĒāĻžāϤāĻŋāϤ, āĻā§āĻŦāĻžāĻŖā§āĻŽā§āĻā§āϤ, āĻ āĻĨāĻŦāĻž āĻĒā§āϰā§āĻŦā§ āĻĢā§āĻāĻžāύ⧠āĻāĻŦāĻ āĻ āĻžāύā§āĻĄāĻž āĻāϰāĻž āĻĒāĻžāύāĻŋ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰā§āύāĨ¤
- āĻĄāĻŋāĻāĻžāĻāϏāĻāĻŋ āĻĒāϰāĻŋāώā§āĻāĻžāϰ āĻāϰā§āύ: āĻĒā§āϰāϤāĻŋāĻāĻŋ āĻŦā§āϝāĻŦāĻšāĻžāϰā§āϰ āĻĒāϰ⧠āύā§āĻāĻŋ āĻĒāĻāĻāĻŋ āĻāĻžāϞā§āĻāĻžāĻŦā§ āϧā§āϝāĻŧā§ āĻļā§āĻāĻŋāϝāĻŧā§ āύāĻŋāύāĨ¤
- āĻšāĻžāϤ āϧā§āϝāĻŧāĻž: āĻĄāĻŋāĻāĻžāĻāϏāĻāĻŋ āĻŦā§āϝāĻŦāĻšāĻžāϰā§āϰ āĻāĻā§ āĻāĻŦāĻ āĻĒāϰ⧠āĻāĻĒāύāĻžāϰ āĻšāĻžāϤ āϧā§āϝāĻŧā§ āĻļā§āĻāĻŋāϝāĻŧā§ āύāĻŋāύāĨ¤
- āĻĄāĻžāĻā§āϤāĻžāϰā§āϰ āϏāĻžāĻĨā§ āĻĒāϰāĻžāĻŽāϰā§āĻļ āĻāϰā§āύ: āύā§āĻāĻŋ āĻĒāĻ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰāĻžāϰ āĻāĻā§ āĻāĻāĻāύ āϏā§āĻŦāĻžāϏā§āĻĨā§āϝāϏā§āĻŦāĻž āĻĒā§āϰāĻĻāĻžāύāĻāĻžāϰā§āϰ āϏāĻžāĻĨā§ āĻāĻĨāĻž āĻŦāϞā§āύ, āĻŦāĻŋāĻļā§āώ āĻāϰ⧠āϝāĻĻāĻŋ āĻāĻĒāύāĻžāϰ āϰā§āĻ āĻĒā§āϰāϤāĻŋāϰā§āϧ āĻā§āώāĻŽāϤāĻž āĻĻā§āϰā§āĻŦāϞ āĻšāϝāĻŧā§ āĻĒāĻĄāĻŧā§ āĻ āĻĨāĻŦāĻž āϏāĻŽā§āĻĒā§āϰāϤāĻŋ āύāĻžāĻā§āϰ āĻ āϏā§āϤā§āϰā§āĻĒāĻāĻžāϰ āĻāϰāĻž āĻšāϝāĻŧā§ āĻĨāĻžāĻā§āĨ¤
- āύāĻŋāĻā§āϰ āĻĻā§āϰāĻŦāĻŖ āύāĻŋāĻā§āĻ āϤā§āϰāĻŋ āĻāϰā§āύ: āĻāĻĒāύāĻŋ āĻĢā§āĻāύā§āϤ āĻāϞā§āϰ āϏāĻžāĻĨā§ āύāύ-āĻāϝāĻŧā§āĻĄāĻŋāύāϝā§āĻā§āϤ āĻā§āĻāĻĄāĻŧā§ āϞāĻŦāĻŖ āĻŽāĻŋāĻļāĻŋāϝāĻŧā§ āĻāĻāĻāĻŋ āϞāĻŦāĻŖāĻžāĻā§āϤ āĻĻā§āϰāĻŦāĻŖ āϤā§āϰāĻŋ āĻāϰāϤ⧠āĻĒāĻžāϰā§āύ, āϤāĻŦā§ āĻĒā§āϰāϤāĻŋāĻŦāĻžāϰ āĻāĻāĻāĻŋ āύāϤā§āύ āĻŦā§āϝāĻžāĻ āϤā§āϰāĻŋ āĻāϰā§āύāĨ¤Â
HRTD Medical Institute